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Abstract

Large dense core vesicles (LDCVs) form at the trans-Golgi network (TGN) and
mediate the regulated release of neuropeptides and peptide hormones. Despite their
central role to physiology, the mechanisms controlling biogenesis and sorting to LDCVs
is not well understood. Optimizing the retention using selective hooks (RUSH) method in
neuroendocrine cells, we show it is possible to visualize sorting to the constitutive and
regulated secretory pathways in real-time and that the bulk of transmembrane LDCV
cargoes do not sort directly onto LDCVs, but exit the TGN into non-regulated vesicles to
be incorporated to LDCVs at a later step. Additionally, we characterize the TGN
peripheral membrane protein, HID-1, as a LDCV biogenesis factor. We show that
ablation of HID-1 results in defects in cargo storage and regulated secretion, a reduction
in the number of LDCVs with perturbed morphology and biochemical properties, and
results in defects in TGN acidification. Despite the importance of HID-1 to regulated
secretion, little is known about HID-1 domain architecture and it is unclear how HID-1
associates to the TGN. We report that the N-terminus of HID-1 mediates membrane
binding through a myristoyl group in combination with an unidentified binding motif
within the C-terminus, and an interaction with the Golgi protein, Golga5, allows for
targeting to the TGN. Finally, we identify the C-terminus as the functional domain of
ii

HID-1, capable of rescuing the secretion and sorting defects. A point mutation within that
domain, identified in patients with endocrine and neurological deficits, is not functional.
We propose that HID-1 N-terminal and C-terminal domains, in cooperation with Golga5,
ensure specific binding to Golgi membranes and functionality of HID-1.
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Chapter One: General introduction

Introduction to the regulated secretory pathway
The secretion of (neuro)peptides and peptide hormones is essential to many
aspects of biology. They control a wide range of behaviors including feeding, sex, sleep
and wakefulness, learning and memory, and mood (de Wied & van Ree, 1989; Richter,
Woods, & Schier, 2014; Carr, 2002; Argiolas & Melis, 2013). Thus, examination and
dissection of the molecular mechanisms underlying the proper trafficking and secretion
of neuropeptides carries great biological significance.
All eukaryotic cells have the ability to secrete a variety of cargo proteins through
the constitutive secretory pathway (Fig. 1) (Kelly, 1985). Proteins destined for secretion
are synthesized and folded with the endoplasmic reticulum (ER) and are trafficked to the
cisternae of the Golgi apparatus. Upon arrival of the cargo proteins to the trans-Golgi
network (TGN), they are segregated and packaged into constitutive secretory vesicles
where they undergo continuous secretion (Brion & Miller, 1992). Professional secretory
cells, such as neurons or β-cells of the pancreas, have in addition to the constitutive
secretory pathway, a regulated secretory pathway (RSP) (Fig. 1). Similarly, proteins
destined for the RSP are synthesized in the ER but upon reaching the TGN are packaged
1

Figure 1. Secretory pathways within eukaryotic cells.
Cartoon of the constitutive and regulated secretory pathways. The constitutive secretory
pathway mediates delivery of plasma membrane proteins and lipids in an unregulated
manner. The regulated secretory pathway exists only in specialized secretory cell types
and mediates the regulated release of peptides and hormones in response to a specific
external stimulus.
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into a specialized secretory organelle termed the large dense core vesicle (LDCV). Upon
initial formation, the vesicles bud as immature LDCVs and undergo a variety of
maturation steps which can include homotypic fusion, cargo aggregation, membrane
removal, lumen acidification, and protein processing which results in a mature LDCV
(Kögel & Gerdes, 2010).
Under steady state conditions, LDCVs accumulate within the cell and can be primed
and docked for secretion or enter an intermediary region classified as the readily
releasable pool (RRP) (Sørensen, 2004). LDCVs are released in a stimulus-dependent
manner and their exocytosis relies on a transient and local increase in intracellular Ca2+.
However, despite the importance of the RSP and LDCVs, the exact mechanisms
controlling LDCV formation remain still poorly understood.
There are two prevailing models thought to encapsulate the mechanisms of
sorting into the two distinct secretory pathways (Fig. 2) (Arvan & Castle, 1998; Tooze,
1997; Arvan & Halbande, 2003). Within specialized secretory cells, there exists high
concentrations of an assortment of secretory proteins within a single LDCV. This
necessitates efficient mechanisms to properly direct sorting to LDCVs that can
accommodate this wide array of cargo proteins. The first model is described as “sorting
for entry” hypothesis, which is based on the proposal that the TGN acts as the central
sorting station for the biosynthetic transport pathway. It is proposed that a promiscuous
cargo receptor can bind all manner of RSP specific cargoes for sorting into the nascent
LDCV. Additionally, it has also been considered that RSP proteins are specifically bound
to receptors and other RSP proteins can become bound to secretory proteins already
3

Figure 2. Models of sorting to the regulated secretory pathway.
Representation of two models of large dense core vesicle biogenesis. The sorting by entry
model postulates that components of large dense core vesicles are specifically sorted
based on protein aggregation, receptor interaction, or other specific sorting motifs. The
sorting by retention model proposes that bulk flow of proteins enter immature secretory
granules. It isn’t until later maturation steps where aberrant proteins are removed from
the forming large dense core vesicle.
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associated with the budding granule. This model views the TGN as a “gatekeeper” that
allows only RSP specific cargo proteins to enter nascent LDCVs, while excluding other
proteins. The second proposed model is the “sorting by retention” hypothesis. This model
is predicated on the idea that the ISG is the critical sorting station for biosynthetic
cargoes. Proteins enter ISGs through the free fluid volume of all vesicle trafficking
pathways. Removal of non-LDCV associated proteins then occurs passively, and is
thought to be either receptor-mediated or through fluid phase vesicular egress.
Additionally, aggregation of LDCV specific components assists in proper retention with
the ISG and an active “exit” route ushers out proteins destined for other biosynthetic
routes.
Many studies have been performed in an attempt to build a case for either
hypothesis with evidence that both supports and weakens both arguments. Studies
supporting sorting by entry have primarily been focused on identifying cargo receptors
that mediate the proper integration of cargoes into LDCVs via receptor-substrate
stoichiometry (Thiele, et al., 1997). For example, carboxypeptidase E (CPE) has been
thought to act as a sorting receptor within neuroendocrine tissues, a function completely
independent of its enzymatic activity. It has been observed that CPE could directly bind
proopiomelanocortin (POMC) and adrenocorticotrophic hormone (ACTH) and this
interaction could be displaced by other regulated secretory proteins (e.g., chromogranin
A, proinsulin). Members of the vacuolar protein sorting 10 (VPS10) family have also
been shown to act as sorting receptors (Lane, et al., 2012). SorCS1, which has been
implicated in diabetes and Alzheimer’s disease, has been shown to be important for
5

proper trafficking of neurexin and AMPA receptors to synapses in neurons (Savas, et al.,
2015). In β-cells overexpression of the SorCS1 lumenal domain, which acts as a
dominant-negative, reduced insulin secretion and LDCV formation, suggesting a
potential role in insulin sorting (Kebede, et al., 2014). Sortilin, another VPS10 protein,
has been shown to bind neurotrophins nerve growth factor (NGF) and brain derived
neurotrophic factor (BDNF), presumably as a sorting receptor in neurons (Lane, et al.,
2012). In agreement with this, sortilin has been implicated in neurodegenerative disease.
Evidence supporting the sorting by entry hypothesis has also attempted to identify
sorting domains or motifs that are consistent among LDCV specific cargoes. A sorting
motif that has been proposed to control proper sorting to LDCVs is an N-terminal
disulphide loop found in POMC, provasopressin, pro-oxytocin, prodynoprhin,
proenkephilin, and chromogranins A and B (Tooze, 1997). This motif is important for
incorporation into LDCVs in pituitary gland AtT20 cells and pheochromocytoma PC12
cells. Indeed, treatment of PC12 cells with the redox reagent DTT, which disrupts
disulfide bridges, resulted in constitutive release of chromogranin B (Tooze, 1997).
Despite this compelling evidence, not all soluble LDCV cargoes contain a disulfide bond,
further complicating the foundations of this hypothesis.
Studies supporting the sorting by retention hypothesis have primarily relied on
analysis of the biosynthetic routes of proteins of various compartmental fates (i.e., LDCV
fated-proteins vs lysosomal-fated proteins) and at what point they diverge. Sorting by
retention has been studied in great detail in pancreatic β-cells (Arvan & Castle, 1998).
The primary cargo for LDCVs within β-cells are proinsulin hexamers, however, they are
6

frequently accompanied by lysosomal prohydrolases. Additionally, proinsulin is further
processed during the LDCV maturation process, forming higher order insulin crystals,
resulting in the C-peptide as a by-product of proinsulin to insulin conversion. The soluble
C-peptide along with the lysosomal prohydrolases have been observed leaving maturing
vesicles in a constitutive like process. In support of this, under unstimulated conditions,
constitutive secretion is enriched in newly synthesized C-peptide in relation to newly
synthesized insulin.
Evidence for the removal of aberrant proteins and processing intermediates is
necessary for the foundation of the sorting by retention hypothesis (Arvan & Castle,
1998). In β-cells, patches of clathrin-coated patches and buds have been seen on ISGs
which is likely the underlying mechanism for removal of anomalous proteins. Studies
that stimulate cells to undergo exocytosis with biosynthetically labeled proteins have
shown that newly synthesized proteins that enter ISGs do not remain in the regulated
secretory pathway. For example, the lysosomal hydrolases cathepsin B and L, have been
shown to enter ISGs and can be secreted early in the LDCV maturation pathway, but their
secretion is reduced with increasing LDCV maturation. In exocrine AtT20 cells, the
biosynthetically labeled constitutive cargoes exocrine amylase and proline-rich secretory
protein enter ISGs as efficiently as the regulated cargo, POMC. Following ISG
maturation, these proteins are undetected in the RSP and can be recovered from
unstimulated secretion. In the model system Aplysia, the egg-laying hormone (ELH)
precursor leaves the TGN in ISGs where it is processed into the mature form. While
mature ELH is retained in LDCVs, the cleavage product is detected in large early
7

granules (LEGs), suggesting removal during maturation. Similarly, if ELH is
exogenously expressed in AtT20 cells, a portion of the proteolysed ELH is stored in
LDCVs while the cleavage products are rapidly secreted or degraded, garnering further
evidence for the sorting by retention hypothesis (Arvan & Castle, 1998; Tooze, 1997).
Despite the various lines of evidence that support either of the two hypotheses, the
exact dichotomy of these two pathways is still not understood. Indeed, these two
pathways may not be mutually exclusive and could exist in different cell types or be
cargo specific. An approach that considers the marriage of the two pathways may be
essential to further elucidate the complexities of LDCV cargo sorting.

Components of the regulated secretory pathway
Initially it was thought that lumenal interactions of secretory proteins were the
main driver for LDCV biogenesis (Tooze & Stinchcombe, 1992). As RSP cargoes move
through the biosynthetic pathway, from the ER to the TGN, the lumenal milieu becomes
more acidic and Ca2+ concentration increases. These factors have been shown to induce
aggregation of soluble proteins, such as proteins of the granin family (Chanat & Huttner,
1991). These protein aggregates are believed to interact with sorting receptors on the
lumenal side of the TGN, resulting in segregation from other biosynthetic pathways and
sorting into the nascent LDCV (Tooze, 1997). In what is considered the “budding
hypothesis,” this large aggregate cannot interact with cargo receptors in a 1:1 ratio; rather
it can partially interact with TGN membranes and induce the budding and subsequent
formation of the ISG. This hypothesis is supported by the observation that small
8

populations of soluble cargo proteins exist as membrane bound molecules presumed to be
through homophilic interactions with membrane or heterophilic interactions with
membrane embedded proteins (i.e., receptors) (Tooze, 1997). Despite these findings, no
ubiquitous LDCV cargo receptor has been identified.
In the recent decades, many other factors have been identified and have been
proven to be essential for proper LDCV biogenesis. Lipids, for example, have been
shown to be essential for LDCV formation (Kim, et al, 2006). Diacylglycerol (DAG) has
been shown to mediate LDCV biogenesis by recruiting protein kinase D (PKD) to Golgi
membranes to mediate membrane fission. Phosphatidic acid (PA), which is converted
from DAG, has been shown to form conical structures under low pH and submillimolar
Ca2+ concentrations, conditions reminiscent of the TGN lumen (Kim, et al., 2006). This is
proposed to mediate vesicle budding by inducing negative membrane curvature of TGN
membrane. In support of this, if PA formation was increased in GH3 cells, budding of
LDCVs was increased (Chen & Shields, 1996). In contrast, if PA synthesis was inhibited,
secretion of growth hormone was decreased (Siddhanta, et al, 2000). Cholesterol, in
combination with sphingomyelin and glycosphingolipids, form tightly packed lipid rafts
on TGN membranes from which LDCVs can bud from. These lipid rafts are also believed
to act as sorting signals to the RSP (Dhanvantari & Loh, 2000). For example, when
cholesterol was depleted in AtT-20 cells accumulation of dense cores was observed at the
TGN with few LDCVs. This effect was reversed following the addition of cholesterol
(Wang, et al, 2000). Phosphoinositides (PI) also contribute to LDCV formation. The
primary PI at the TGN, PI(4)P, recruits ADP ribosylation factor (Arf) proteins to TGN
9

membranes which has been shown to be important for vesicular biogenesis, membrane
trafficking, and cargo selection (Kim, et al., 2006).
Transcription and translation factors have also been implicated in LDCV
biogenesis. Expression profiling of glucose stimulated insulinoma MIN-6 cells or
secretion incompetent PC12 cells that can no longer generate LDCVs had significant
changes in expression of genes involved in nuclear transcription factors, mRNA
processing, and translation, suggesting a complex program of transcriptional and
posttranslational factors that modulate LDCV biogenesis (Kim, et al. 2006). For example,
the transmembrane protein, IA-2, influences transcriptional regulation of LDCV
biogenesis in response to glucose stimulated secretion (Borgonovo, et al., 2006; Park, et
al., 2009; Kim, et al., 2006). The receptor element 1-silencing transcription factor (REST)
has been shown to negatively regulate genes essential to LDCV biogenesis (Park, et al.,
2009). REST binds a region of DNA known as repressor element 1 and causes the
suppression of SNAP receptor (SNARE) proteins and other LDCV proteins. The RNA
binding protein, polyprimidine-tract binding protein (PTB), has been shown to stabilize
insulin and other LDCV protein mRNA following glucose stimulation in β-cells, which
presumably induces LDCV biogenesis by increasing LDCV protein synthesis (Kim, et
al., 2006; Park, et al., 2009). In support of this notion, knockdown of PTB in insulinoma
INS-1 cells resulted in decreased expression of LDCV proteins and the disappearance of
LDCVs (Park, et al., 2009).
Finally, a wide array of cytosolic proteins have been identified as LDCV
biogenesis factors. Bin/Amphiphysin/Rvs (BAR) domains are crescent shaped, dimeric,
10

α-helical regions that are capable of sensing, inducing, or stabilizing membrane curvature
and many BAR-domain containing proteins have been implicated in LDCV biogenesis
(Habermann, 2004). Protein interacting with C kinase 1 (PICK1) is a Bar-domain protein
has been shown to be important for LDCV formation. Mouse chromaffin cells lacking
PICK1 were shown to have reduced number of LDCVs that were markedly reduced in
size; however, these LDCVs were still competent for exocytosis with reduced quantal
size (Pinheiro, et al., 2014). Another Bar-domain protein, Islet cell autoantigen 69kDa
(ICA69), has been observed associated with the TGN and ISGs and acts as a rab2 effector
in LDCV biogenesis and maturation (Cao, et al., 2013). Interestingly, heterodimerzation
of PICK1 and ICA69 has been observed to be important of ISG maturation in β-cells
(Cao, et al., 2013). Another Bar-domain containing protein, arfaptin-1, has been shown to
mediate LDCV budding by regulating the scission step from the TGN (Gehart, et al.,
2012). Arfaptin-1 binds to the neck of a budding vesicle and prevents scission until it is
phosphorylated by PKD resulting in dissociation of arfaptin-1 and subsequent vesicle
scission. Loss of arfaptin-1 results in the formation of small and nonfunctional LDCVs,
suggesting arfaptin-1 acts at an important checkpoint step that prevents vesicle fission
until all necessary components are sorted onto the nascent LDCV.
Rab small GTPases constitute the largest family of known membrane trafficking
proteins and have been extensively studied (Fukuda, 2008). Indeed, many Rab proteins
have been implicated in LDCV biogenesis. In C. elegans, Rab5 and Rab10 and their
effectors, TBC-2 and TBC-4 respectively, are important for LDCV formation and
subsequent exocytosis (Sasidharan, et al., 2012). Rab33 has been shown to be important
11

for proper amylase release from LDCVs of parotid acinar cells and for proper exocytosis
in PC12 cells (Imai, et al., 2015). Rab3 and Rab27, while typically thought to be
important for docking and exocytosis of LDCVs, has also been shown to be involved in
LDCV formation. In the exocrine pancreas of Rab3D knock-out (KO) mice, LDCVs are
significantly larger, whereas Rab27B KO mice have severely reduced number of LDCVs
(Fukuda, 2008). Rab2 is primarily localized to the Golgi and influences proper sorting of
soluble and transmembrane cargoes to LDCVs (Sumakovic, et al., 2009). In addition,
many Rab2 effectors have been shown to be important in proper LDCV formation. The
Rab2 effectors CCCP-1 and RUND1 are recruited to the Golgi by Rab2 and assist in
sorting of soluble and transmembrane cargoes to LDCVs (Ailion, et al., 2014). The Bardomain protein, ICA69 (described above) is recruited to Golgi membranes by Rab2 to
exert its function in LDCV maturation (Cao, et al., 2013). TBC-8 was shown to be a
Rab2 GTPase activating protein (GAP) that mediates LDCV maturation by controlling
Rab2 cycling at the Golgi (Hannemann, et al., 2012). Finally, the recently identified Rab2
effector, HID-1, has been shown to be crucial for LDCV biogenesis in C. elegans and
mammalian neuroendocrine cells (Ailion & Thomas, 2003; Du, et al., 2016; Hummer, et
al., 2017).
Other cytosolic factors that have been identified in LDCV biogenesis include
Arf1, a GTP binding protein, has been shown to initiate LDCV budding from the TGN in
conjunction with arfaptin-1 (Chen & Shields, 1996). The Arf guanine exchange factor
(GEF), BIG3, has been shown to be a negative regulator of insulin secretion by inhibiting
LDCV biogenesis (Li, et al., 2014). Adaptor protein-3 (AP3) and its putative coat protein,
12

VPS41, have been shown to be important for sorting of cargo to LDCVs and for proper
LDCV formation (Asensio, et al., 2010; Asensio, et al., 2013). The clathrin adaptor
protein, Golgi-associated γ-ear containing ADP-ribosylation factor-binding protein
(GGA), has been shown to be crucial for LDCV maturation in neuroendocrine cells
(Kakhlon, Sakya, Larijani, Watson, & Tooze, 2006). The EARP complex and its
interactor EIPR-1 influences LDCV biogenesis by mediating proper sorting and retention
of cargoes in LDCVs (Topalidou, et al., 2016; Topalidou, Cattin-Ortolá, Hummer,
Asensio, & Ailion, 2019). Ca2+-activator protein for secretion (CAPS) localizes to LDCV
membranes and is required for the maintenance of the RRP of LDCVs (Liu, et al., 2008).
Loss of BAIAP3, a C2 domain containing protein, in INS-1 cells results in accumulation
of fusion incompetent LDCVs that were subsequently degraded via crinophagy,
suggesting a role in maintaining proper LDCV protein composition (Zhang, et al., 2017).
Despite the existing uncertainties of the exact mechanisms of LDCV biogenesis,
many factors have been identified and show a broad range of function affecting LDCV
formation, including cargo sorting, membrane modeling and deformation, budding,
scission, and maturation. Elucidating the complex interplay and cascades of the various
cytosolic proteins identified will be crucial to creating a complete picture of LDCV
biogenesis.

Tools for studying the regulated secretory pathway
Many tools have been developed over the past four decades in an attempt to
address the ephemeral process of LDCV biogenesis. After the observation that endocytic
13

and exocytotic trafficking is perturbed at low temperatures in mammalian cells, assays
were developed to arrest membrane trafficking (Matlin & Simons, 1983). This initial
finding led to the observation that incubation of mammalian cells between 16-20C led to
arrested transport from the ER to the Golgi (Saraste et al., 1986), as evidenced by
microsomes containing RNA or newly biosynthetically labeled synthesized proteins.
Additionally, electron micrographs of cells incubated at low temperatures showed an
accumulation of vesicles at the cis-Golgi, presumably trapped at the transitional site
between the ER and the Golgi. While this technique is effective and fairly simple to
perform, there are shortcomings. First, this method is not inherently perfect at blocking
traffic; there is still some “leakiness” into the secretory pathway, which contributes to
background signal and muddles the distinction between newly made and existing
LDCVs. Second, reduction in temperature not only stops trafficking through the secretory
pathway, but effectively almost all other cellular processes, resulting in this method not
being physiologically representative.
Another classic temperature-dependent method for analyzing trafficking through
the secretory pathway is the use of a temperature-sensitive mutant of the vesicular
stomatitis virus (ts045VSVG) (Lafay, 1974). It has been demonstrated that a single
mutation within the exoplasmic loop of the VSVG protein causes temperature-sensitive
surface transport defects. Proper folding and trafficking of ts045VSVG is blocked when
cells are cultured at 39C. Once cells are moved to the permissive temperature, 30C, the
blockade is released and normal trafficking of ts045VSVG can occur. This trafficking is
mediated by the oligomerization of the G protein, which cannot occur at the non14

permissive temperature (Kreis & Lodish, 1986). Trafficking from the ER through the
secretory pathway has been extensively analyzed through the use of ts045VSVG both
biochemically and with imaging techniques. Radioactive labeling of VSVG at the nonpermissive temperature followed by incubation for various time points has given insight
into the temporal nature of trafficking to the different compartments of the RSP. The use
of the fluorescent tag, GFP, fused to the cytosolic domain of ts045VSVG resulted in the
first visualization of trafficking through the secretory pathway in living cells (Presley, et
al., 1997). While this method is extremely powerful and reliable, it still relies on the
exogenous introduction of viral proteins within a mammalian cell background. Thus, the
information obtained regarding trafficking through the mammalian secretory pathway
with a foreign protein may not be sufficiently representative in comparison to
endogenous cargo proteins.
One of the original methods used to analyze sorting of cargoes between the
constitutive and regulated secretory pathway was pulse-chase labeling using radioactive
sulfate (Tooze & Huttner, 1990). This cell free system relies on the post-translational
modification that occurs specifically with the lumen of the TGN allowing for precise
spatial control for labeling of cargo proteins. The regulated secretory pathway cargoes
secretogranin I (SgI) and secretogranin II (SgII) are the two major proteins that are
sulfated in the neuroendocrine PC12 cell line. Additionally, PC12 cells contain sulfated
proteoglycans (hsPGs) that are constitutively secreted, allowing for dissemination of the
two pathways. This system relies on the initial “pulse” of radioactive sulfate, followed by
“chasing” for determined periods of time to allow for trafficking of the sulfated cargo
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proteins. Following the chase period, postnuclear supernatants are subjected to organelle
density sedimentation to separate constitutive vesicles and LDCVs within a gradient.
Analysis of different vesicle populations revealed that constitutive and regulated
secretory proteins colocalize within the TGN compartment and indeed are segregated
within two distinct vesicle post-TGN carriers, ISGs and constitutive secretory vesicles,
and that segregation of these specific cargoes appears to occur immediately upon TGN
exit. Finally, these studies demonstrated that immature granules are subject to maturation
following budding from the TGN, and thus are an intermediate carrier to mature LDCVs.
Despite this classical method to biochemically track cargo movement through the
secretory pathway, the major drawback of using this method is due to the use of
radioactive materials and is not applicable to all cargoes, in particular transmembrane
proteins that are not released into the supernatant following secretion. Not only does this
require a level of expertise, and proper equipment and space, working with radioactive
materials is inherently dangerous and should be avoided if possible.
Another method used to study trafficking through the RSP is by synchronizing the
traffic of cargo proteins. This has been accomplished through the process of controlled
protein aggregation (Rivera, et al., 2000). This method traps proteins of interest in the ER
by fusing them to a conditional aggregation domain (CAD), a domain that interacts with
itself and can be reversed in a ligand dependent manner. Aggregation of the CAD domain
results in protein aggregates that are too large to be transported in vesicles that leave the
ER. To generate the CAD, mutation of the FKBP12 protein converted it into a CAD with
the ability to form dimers with micromolar affinity. Application of a small synthetic
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ligand disrupts the CAD aggregation and rapidly clears the aggregates to allow for proper
trafficking and subsequent secretion of the protein of interest. In order to preserve the
function of the protein of interest, the CAD is flanked by a furin cleavage site to allow for
removal of the CAD upon entry to the Golgi. Despite the power of synchronizing traffic
through the RSP, there are caveats to this approach; one being to the potential for cellular
stress. Using CAD fusion proteins resulted in distension of the ER, likely resulting in the
ER stress response. Moreover, addition of ligands can potentially result in off target
effects or be cytotoxic. Finally, reliance on proper furin cleavage could be a rate limiting
factor resulting in perturbed trafficking. Indeed, the CAD fusion with insulin was
observed to only be cleaved with ~50% efficiency, suggesting defects in either protein
processing or a saturation affect when an abundance of molecules are rapidly being
trafficked from the ER to the Golgi.
An alternative approach to trap cargo proteins in the ER is with FKBP-FRB
protein interactions (Sengupta, et al., 2015). The FKBP-FRB is a chemically induced
dimerization system that results in the formation of a ternary complex between FKBP and
FRB in the presence of the ligand, rapamycin. This method that has been used to observe
cargo trafficking employs the use of an endogenously expressed ER protein, FKBP13,
with expression of an FRB tagged target protein. In the presence of rapamycin, a complex
is formed, and FRB tagged cargo proteins are retained within the ER. Following washout,
the interaction is abolished and allows for proper trafficking of cargo proteins. A benefit
to this approach is the use of not only an endogenous “trap” protein, but also the acute
nature of the drug treatment. However, rapamycin is a specific inhibitor of mTOR
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pathway (Li, et al., 2014), the master regulator of cell growth and metabolism, thus the
use of this drug could have unintended consequences.
There are also many drug-mediated approaches to studying trafficking. A
common drug that is frequently combined with temperature induced Golgi block is
cycloheximide. This drug prevents protein synthesis and, when combined with Golgi
block, can be used to reduce that amount of noise that is present within a leaky system.
This ensures that the wave of cargo seen following release of the Golgi block is newly
synthesized protein, making interpretation significantly easier. Cycloheximide is highly
toxic, however, forcing it to be used as a very acute treatment. Another drug that has been
used to study the secretory pathway is brefeldin A (BFA) (Miller, et al., 1992; Salomon
& Meindl, 1996; Powell, 2006). BFA stabilizes the guanine exchange factor (GEF) for
Arf1, a key regulator of Golgi architecture, on Golgi membranes. This results in Arf1
inactivation and exaggerated retrograde trafficking coupled with inhibited anterograde
traffic. This effectively results in all secretory cargoes being sent back to the ER.
Following removal of the BFA, the effect is reversed and allows for trafficking to
resume, resulting in a synchronized egress of cargo proteins. A similar drug, Golgicide A
(GCA), is also used to block Golgi traffic. GCA also inhibits the Arf1 GEF, GBF1,
essentially recapitulating the effects of BFA. Both BFA and GCA are highly toxic to
cells, making them unideal treatments. BFA and GCA also cause the Golgi to collapse
back onto the ER (Powell, 2006), which could ultimately disrupt trafficking even after
removal of the drugs. Another drug frequently used to block the secretory pathway is
monensin (Griffiths, et al, 1983; Ueda, et al., 1985; Neil-Anderson, et al., 2002).
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Monensin is an ionophore that disrupts the intracellular Na+/H+ gradient that most
robustly affects the Golgi. Monensin appears to block movement of cargo proteins from
the medial to the trans-Golgi cisternae, consequently resulting in accumulation of cargoes
and a swollen Golgi apparatus. This effect is reversible, and removal of monensin can
restore proper trafficking. However, monensin is toxic to cells and is less effective at
completely blocking trafficking in comparison to BFA, making it a less desirable
treatment for studying the secretory pathway.
These seminal studies were critical to begin uncovering some of the molecular
mechanisms underlying trafficking though the regulated secretory pathway. While very
important and cutting edge for their time, new and more effective tools are required for
further study of the regulated secretory pathway. One of the most recently developed
tools is the Retention Using Selective Hooks (RUSH) system (Boncompain, et al., 2012).
The RUSH system depends on the expression of two fusion proteins: the hook, which is
stably expressed in the donor compartment and is fused with streptavidin, and the
reporter, which interacts with the hook via a streptavidin binding protein (SBP). At
steady state, this streptavidin-SBP interaction allows the reporter protein to be efficiently
hooked within the donor compartment (typically the ER). This interaction is reversible
upon the addition of exogenous biotin, which liberates the reporter protein allowing it to
traffic normally through the secretory pathway, resulting in complete synchronization of
cargo proteins. This system has been shown to result in little to no ER stress and did not
affect ER morphology, suggesting that this technique is relatively nontoxic to cells. The
RUSH system has been shown to be compatible with a wide range of different cargo
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proteins and allows for imaging of two cargoes simultaneously with the only limiting
factor being determination of the appropriate region within the reporter protein to insert
the SBP. Finally, the RUSH system allows for visualization of cargo trafficking and
sorting at physiological temperatures and conditions, and without the use of drugs aside
from biotin, a natural and nontoxic vitamin. This elegant system allows for the
characterization of sorting mechanisms at the Golgi of a wide range of cargo proteins and
different cell backgrounds.

Significance of studying the regulated secretory
The significance of the RSP is unquestionable to proper physiology and behavior,
and perturbations in components of the RSP have been linked to a variety of
neuropsychiatric and metabolic disorders. Single nucleotide polymorphisms (SNPs)
within proteins of the RSP have shown to be the basis for many diseases (Willis, et al,
2011). SNPs within alleles encoding the neurotrophins brain derived neurotrophic factor
(BDNF) and nerve growth factor (NGF) have been implicated in Alzheimer’s disease and
attention deficit hyperactivity disorder (ADHD). Mutations within the gene of the
pituitary hormone POMC have been linked to severe obesity (Salton & Lin, 2013).
Additionally, SNPs in the agouti-related peptide (AgRP) and neuropeptide Y, both
orexigenic peptides, have been linked with increased food intake and obesity. Proteins of
the granin family, which have been shown to be important in LDCV biogenesis, have
been linked to a plethora of disorders as well (Willis, et al., 2011). SNPs in chromogranin
A and B are linked to hypertension. SNPs in an intron within the secretogranin II (sgII)
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gene and the promoter region of the secretogranin III (sgIII) gene have been linked to a
multitude of metabolic diseases including hypertension, dyslipidemia, cardiovascular
disease, and glucose tolerance. Members of the granin family have also been implicated
in Alzheimer’s disease, with chromogranin A and B, and SgII having been found in up to
60% of amyloid plaques.
Likely the most notable disease stemming from perturbations of the RSP is
diabetes mellitus (DM) type I and II (Kharroubi & Darwish, 2015). DM is a group of
metabolic diseases characterized by chronic hyperglycemia due to defects in insulin
secretion or action. Type I DM accounts for ~5-10% of all subjects diagnosed with DM
and accounts for the vast majority of DM in children. Type I DM is primarily caused by
the autoimmune destruction of β-cells, resulting in an inability to efficiently secrete
insulin in response to increased blood glucose. Type II DM, on the other hand, is
primarily characterized by insulin resistance. Insulin resistance leads to increased demand
for circulating insulin, putting increased stress on β-cells. This chronic stress on β-cells to
secrete insulin can result in destruction of β-cells, which makes the patient dependent on
exogenous insulin. Type II DM is significantly more common, accounting for up to 95%
of cases, with obesity being one of the primary reasons for development of insulin
resistance. Both forms of DM have been shown to have an underlying genetic basis and
many studies have attempted to elucidate the wide spectrum of genes that contribute to
the etiology of the disease. Mutations can occur in the actual insulin gene, downstream
substrates of the insulin pathway, or in proteins peripheral to the insulin pathway (Das &
Elbein, 2006). A nucleotide variation within the C-peptide of the insulin hormone has
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been shown to affect proper processing, which results in circulation of a defective
intermediate peptide which consequently leads to hyperinsulinemia. Another proinsulin
SNP reroutes proinsulin to the constitutive pathway, again affecting processing into the
mature peptide and leading to aberrant secretion. Two major SNPs were found to be
closely linked to development of type I DM that affects the immune system (Kharroubi &
Darwish, 2015). These include the autoimmune regulator (AIRE) gene, which modulates
immune tolerance to self-antigens, and the FOXP3 gene which results in defective
regulatory T cell function. SNPs within the protein tyrosine phosphatase 1B (PTPN1)
gene, which negatively regulates insulin signaling by acting on the insulin receptor
kinase, has been implicated in type II DM. Variants within the cell K+ channel subunits,
KCNJII and ABCC8, have both been associated with type II DM by reducing insulin
secretion and reducing the K+ channel sensitivity to ATP, respectively. A vast pool of
candidate genes have been identified to be the underlying cause of both type I and II DM,
revealing the complexity of the genetic landscape of this disease and of all the factors that
contribute to the proper function of the RSP.
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Chapter Two: Materials and methods

Molecular Biology
All constructs were verified by Sanger sequencing (Quintarabio). Primers were
obtained from IDT and restriction enzymes from NEB. All primers used are included in
Table S1. HID-1 lentiviral plasmid was generated by amplifying HID-1 from rat PC12 cell
cDNA using the following primers: P1_F and P1_R. The main isoform amplified from
these cells corresponds to isoform #2, which has been reported for mouse (Uniprot:
Q8R1F6-2) and for human (Uniprot: Q8IV36-2). The PCR products were then subcloned
into pLenti-puro using the restriction enzymes XbaI and BstEII. The G2A and Δ22 HID-1
mutant plasmids were constructed by amplifying from the WT HID-1 pLenti-puro plasmid
using the following primers: G2A Forward: P2_F and P2_R; P3_F and P3_R. The PCR
products were subcloned into pLenti-puro using the restriction enzymes XbaI and BstEII.
HID-1 C-terminus human mutation was amplified from WT HID-1 and cloned in pLentipuro by Gibson using the following primers: P4_F and P4_R. The GFP-TGN38-HID-1 Cterminus fusion was made by amplifying GFP-TGN38 from a premade plasmid using the
primers: p5_F and P5_R. The HID-1 C-terminus was amplified from WT HID-1 using the
primers: P6_F and P6_R. These PCRs were cloned into the pCAGG vector by Gibson. The
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cytosolic fragment of Golga5 was amplified from WT Golga5 using the primers: P7_F and
P7_R, and subcloned into pCAGG containing an N-terminal GFP via Gibson. HID-1-GFP
tail fusions were amplified with the following primers: pEGFP-N1-HID-1-N22: P8_F and
P8_R; pEGFP-N1-HID-1-N22(G2A); P9_F and P9_R; pEGFP-N1-HID-1-N17: P10_F
and P10_R; pEGFP-N1-HID-1-N17(FVL); P11_F and P11_R; pEGFP-N1-HID-1N17(KRK); P12_F and P12_R. PCRs were subcloned into pEGFP-N1 using BamHI and
AgeI. HID-1 was amplified from the pLenti-HID-1 construct with the following primers:
P13_F and P13_R. HID-1 G2A was amplified from the pLenti-HID-1-G2A construct with
the following primers: P14_F and P14_R. Both constructs were then cloned, via Gibson
assembly, into a pFastBac vector with a C-terminal twin-strep-tag. The HID-1 365-551
fragment was amplified from HID-1 WT with the following primers: P15_F and P15_R.
The HID-1 682-788 fragment was amplified from HID-1 WT with the following primers:
P16_F and P16_R. The fragments were then cloned into a pET15b vector with a C-terminal
MBP and TEV protease site as well as N-terminal HA tag using Gibson Assembly. The
HID-1 truncation constructs were amplified using the following primers: FUGW-HID-1(1583)-HA: P17_F and P17_R; FUGW-HID-1(1-686)-HA: P18_F and P18_R; FUGW-HID1(321-788)-HA: P19_F and P19_R; FUGW-HID-1(321-583)-HA: P20_F and P20_R;
pLenti-HID-1(587-788)-HA: P21_F and P21_R; pLenti-HID-1(686-788)-HA: P22_F and
P22_R. PCRs were subcloned into FUGW or pLenti-puro using Gibson reaction. MCSHID-1-BioID2-HA and MCS-HID-1-13X-BioID2-HA was made by amplifying WT HID1 using the following primers: P23_F and P23_R; P24_F and P24_R, respectively. PCRs
were subcloned into a BioID2-HA containing plasmid acquired from Addgene using the
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restriction enzymes AgeI and BstEII. Soluble BioID2 was made by amplifying from the
BioID2 plasmid acquired from Addgene using the primers: P25_F and P25_R, and
subcloned into FUGW using the restriction enzymes AgeI and BstEII. In order to make the
HID-1-BioID2 lentiviral plasmids (FUGW-HID-1-BioID2-HA, FUGW-HID-1-13XBioID2-HA), HID-1-BioID2 was amplified from the previously designed plasmids using
the primers: P26_F and P26_R; P27_F and P27_R, and subcloned into FUGW using AgeI
and BstEII. Previous studies utilizing RUSH performed the assay using a bicistronic
plasmid containing an ER hook (KDEL-streptavidin) followed by a “hookable” cargo after
an IRES (Boncompain et al., 2012, Chen et al., 2017, Emperador-Melero et al., 2018).
When these cargoes were tested in COS-7 cells, they behaved as expected (data not shown),
but they did not in (neuro-)endocrine cells. The fusion proteins expressed at very low levels
and the cells did not display any RUSH upon biotin addition. To alleviate this, we
expressed the hook and cargo using two separate plasmids, which solved the issue of low
expression, however, this alone did not allow for RUSH to occur due to cargo not being
hooked properly. We further engineered our ER hook by introducing a linker between the
streptavidin and the KDEL sequence. This modification was essential and sufficient to
enable efficient hooking at the ER. All constructs used were generated using pemdGFPC3
as a backbone. STR-HA-KDEL: HA-KDEL was produced by annealing P37_F and P37_R.
The product was used in a ligation reaction with pemdGFPC3-STR cut with Sbf1 and Sac1.
To generate STR-Linker-KDEL, we introduced a flexible linker by annealing P38_F and
P38_R and ligating into STR-HA-KDEL cut with SbfI and SacI, which removed the HA.
To generate NPY-emdGFP-SBP, we amplified NPY using P28_F and P28_R, emdGFP
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using P29_F and P29_R, and SBP using P30_F and P30_R. We performed overlap
extension PCR using emdGFP and SBP fragments. NPY, emdGFP-SBP, and pemdGFPC3
cut with AgeI and EcoR1 were used in a three-part Gibson reaction. To generate NPY-HASBP, HA was obtained by annealing P31_F and P31_R. The annealed primers were used
in a ligation reaction with NPY-emdGFP-SBP cut with HindIII and SacI, which removed
emdGFP. To generate phogrin-emdGFP-SBP, phogrin’s lumenal domain up to the
transmembrane domain was amplified using P32_F and P32_R. emdGFP-SBP was
amplified using P33_F and P33_R. The remaining portion of phogrin’s lumenal domain
and the transmembrane plus cytosolic domain was amplified using P34_F and P34_R. The
emdGFP-SBP and cytosolic portion of phogrin underwent overlap extension. We
introduced emdGFP-SBP within the lumenal domain (after amino acid 588). This construct
was designed based on the extensive, unpublished work done in the laboratory of the late
John Hutton, where a pHluorin-phogrin fusion was generated (Bauer, 2008). This construct
was validated by showing that, at this particular site, the insertion of the fluorescent protein
did not affect the trafficking of phogrin in INS-1 cells. To generate SgII-emdGFP-SBP,
SgII was amplified using P35_F and P35_R and ligated pemdGFPC3-emdGFP-SBP cut
with AgeI and HindIII. To generate SBP-emdGFP-VSV-G, VSVG was amplified using
P36_F and P36_R. A vector containing SBP-emdGFP was cut with EcoRI and KpnI. PCR
and vector were used in a Gibson reaction to generate SBP-emdGFP-VSVG. To generate
VMAT2-emdGFP-SBP, we inserted emdGFP-SBP within the first lumenal loop of
VMAT2. Indeed, insertion of pHluorin at this particular site does not affect VMAT2’s
trafficking (Anantharam et al., 2010). To amplify emdGFP-SBP, we used P37_F and P37_R
26

and ligated into pemdGFPC3-VMAT2 cut with AgeI. To generate NPY-mCherry-SBP, we
amplified mCherry using P38_F and P38_R and ligated within NPY-emdGFP-SBP cut
with HindIII and SacI.

Cell culture and lentivirus production
INS-1 cells were maintained in RPMI supplemented with 2mM sodium pyruvate, 10%
fetal bovine serum and 50mM β-mercaptoethanol under 5% CO2 at 37°C. PC12 cells were
maintained in DMEM supplemented with 10% horse serum and 5% calf serum under 5%
CO2 at 37°C. Transfection of PC12 and INS-1 cells was performed using Fugene HD
(Promega) according to the manufacturer’s instructions. HEK293T cells were maintained
in DMEM with 10% fetal bovine serum under 5% CO2 at 37°C. Lentivirus was produced
by transfecting HEK293T cells with FUGW or pLenti-puro, psPAX2, and pVSVG using
PEI at 1μg/μL in final reaction volume or Fugene HD according to the manufacturer’s
instructions. 24hr after virus application, stably transduced cells were then selected for
~24hr using 3ug/mL puromycin. Transfections for live-imaging were performed using
Fugene HD (Promega, Cat#E2311) according to the manufacturer protocol. For RUSH, a
ratio of 3:1 hook to cargo ratio was determined to be ideal. Lipofectamine 2000 was used
to transfect PC12 cells for secretion assays. Experiments were performed 36-48h after
transfection. Cells were routinely tested for the absence of mycoplasma. For live imaging,
cells were transfected in 24-well dishes (Genesee Scientific, Cat#25-107), trypsinized and
replated 24h post transfection to a 35mm glass bottom imaging dish coated with PLL
(Sigma-Aldrich, Cat#P2636). Cells were imaged the following day. For live imaging, INS27

1 were transferred to biotin and phenol-red free RPMI (US Biological Life Sciences,
Cat#R9002-01) media supplemented with 2.4mM sodium bicarbonate and 25mM HEPES.
PC12 cells were imaged in phenol-red free complete media.

CRISPR/Cas9
The human codon-optimized Cas9 and chimeric guide RNA expression plasmid
(pX330) developed by the Zhang lab were obtained from Addgene (43). To generate gRNA
plasmids, a pair of annealed oligos (20 base pairs) was ligated into the single guide RNA
scaffold of pX330. The following gRNAs sequences were used: Forward2: 5′-CACCGAGCCACCGACAATGCTTTCT-3′;

Reverse2:

5′-AAACAGAAAGCA--

TTGTCGGTGGCTC-3′ to generate HID-1 KO. The following primers were used to
genotype HID-1 KO cells: P1F: 5′-GCACTAAACGGGGAGTCC-3′; P1R 5′GCATAATGGACACTGAAGGTAGGAGG-3′;

P2F:

5′-

GGCATGGACGAGCTGTACAAG-3′; P2R: 5′- CCAGTCCACTGGGATGGC-3′; P3F:
5′-GTGTAACTCTGGCTACTCGATTCC-3′; P3R: 5′-CTTGTAGCACAGGGTGGCC3′. To test for the presence of indels, primers P3F/P3R were used. The resulting PCR
products were ligated into pBluesecript II KS. Isolated plasmids from 24 random colonies
were then analyzed for the presence of indels by sequencing.

Antibodies
HA (3F10) rat mAb was obtained from Roche, SgII rabbit antibody from Meridian Life
Science (USA), TGN38 mouse mAb from BD Biosciences (USA), tubulin and actin mouse
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mAb from Developmental Hybridoma Bank Studies (USA), HID-1 mouse mAb and
Golga5 rabbit mAb from Novus Biologicals (USA), mouse anti-insulin from Sigma (USA),
and goat anti-rabbit Alexa Fluor 647, anti-mouse Alexa Fluor 488, anti-mouse Alexa Fluor
647, and anti-rat Alexa Fluor 488 secondary antibodies from ThermoFisher (USA).

Secretion assays
PC12 cells were plated on poly-l-lysine, washed, and incubated in Tyrode’s buffer
containing 2.5 mM K+ (basal) or 90 mM K+ (stimulated) for 30 min at 37°C. The
supernatant was then collected, cell lysates prepared as previously described (44), and the
samples analyzed by quantitative fluorescence immunoblotting. INS-1 cells were washed
once in PBS, reset in low potassium KRB (138mM NaCl, 5.4mM KCl, 2.6mM MgSO4,
5.0mM NaHCO3, 10mM HEPES, 2.6mM CaCl2, 1.5mM glucose) for 1hr at 37C.
Following an additional PBS wash, cells were incubated with low potassium KRB with
50μM biotin (Sigma-Aldrich, Cat#B4501-1G) for 3h. Cells were washed again with PBS,
and treated with low or high potassium (97.8mM NaCl, 45.6mM KCl) KRB for 15min.
Secreted fractions were collected. Cells were washed with ice cold PBS, and lysed in
50mM Tris, pH 7.4, 150mM NaCl, mM EDTA, 1% TX-100 with protease inhibitors
(Sigma-Aldrich) and 1mM PMSF (Sigma-Aldrich). Secreted fractions and cellular lysates
were prepared and fluorescence was measured using a plate reader as described previously.
PC12 cells were washed with PBS, incubated with complete media in presence of 50μM
biotin for 1.5h at 37C. Following an additional PBS wash, cells were incubated with low
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or high potassium Tyrode buffer for 15min at 37C. Secreted and cellular fractions were
prepared as described above.

Immunofluorescence and confocal microscopy
PC12 and INS-1 cells were rinsed with PBS and fixed in 4% paraformaldehyde in PBS
and incubated for 20 min at room temperature followed by a 20min quenching step with
100nM NH4Cl in PBS for 20min. For saponin extraction experiments, prior to fixation,
cells were treated with 0.1% saponin in PBS for 50s and washed with PBS. Cells were
blocked in PBS containing 2% BSA, 1% fish skin gelatin, and 0.02% saponin. Primary
antibodies were diluted in blocking solution at 1:1000 (TGN38), and 1:500 (HA.11). The
secondary goat anti-rat and donkey anti-mouse antibodies were diluted in blocking solution
at 1:1000. Images were collected with a 63× objective (Oil Plan Apo NA 1.49) and an
ImageEM X2 EM-CCD camera (Hamamatsu, Japan).

Image acquisition and analysis
Images for colocalization analysis were acquired using a custom-built Nikon spinning
disc confocal. Images were collected with a 63× objective (Oil Plan Apo NA 1.49) and an
ImageEM X2 EM-CCD camera (Hamamatsu, Japan) at a resolution of 512 × 512 pixels.
Images for puncta analysis were imaged on an Evos FL Auto 2 microscope using a 63×
objective (Oil Plan Apo NA 1.42, Olympus). Manders correlation coefficient was
determined using the Colocalization Threshold Fiji plugin using an ROI that encompassed
the entire cell but excluded the nucleus and Golgi region. Cells were excluded from
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analysis for tM1 or tM2 values of 1 due to thresholding issues and cells with no positive
correlation were also excluded. Live movies were imaged on an Evos FL Auto 2 in an
environmentally controlled imaging chamber (37C, 5% CO2, 20% humidity). Cells were
imaged every 2 min. Image processing was performed using MATLAB software. To
isolate regions of interest, each frame of the Golgi-labeled channel was manually cropped
around the general cell area and segmented using an intensity threshold filter. The
segmented region of interest was constrained by an area filter to reduce noise, generating
a binary mask of only the largest objects within the frame. The mask was then convoluted
with the cargo channel to obtain the TGN signal, and the inverse of the mask was
convoluted with the same channel to acquire the background signal. For figures, images
were processed using ImageJ, any changes in brightness and contrast were identical
between samples meant for comparison. First order decay curves were fit using GraphPad
Prism version 8.0.2 for Windows, GraphPad Software, La Jolla (California). The plateau
followed by a one phase decay function with a constraint of X0 begin greater than 0 was
used to fit kTGN. The one phase decay function was used to fit kER. Average curves for
experiments with dynasore were made by combining the curves from all cells starting
directly after biotin addition. For phogrin, due to variable RUSH starting time, we aligned
the individual curves at the beginning of ER exit to generate average curves. Statistical
analysis was performed using Prism. The following criteria were used to exclude cells from
further analysis: 1) cell division, 2) excessive Golgi fractionation, or 3) extensive out of
focus drift. Outside of these criteria, all cells were used for analysis. For two cargoes RUSH
experiments, transfected cells were imaged using a spinning-disk confocal 30-40 min after
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biotin addition every 300 ms for 2 min. We determined the proportion of newly budded
vesicles containing both cargoes using the ComDet v.0.4.2 plugin for Image J
(https://github.com/ekatrukha/ComDet) using a circular ROI around the Golgi region with
a diameter equals to twice the diameter of the Golgi. Proportions were obtained for each
frame, and an average proportion per cell was calculated over 150 frames. Line scans were
generated using imageJ by measuring fluorescence intensity from individual frames from
a single movie. Raw fluorescence measurements were normalized to 1 for each fluorescent
reporter included on the line scan. Representative movies were selected from a total of 11
movies for phogrin and VSV-G and 12 movies of SgII. All movies showed a similar affect
in blockade of traffic for transmembrane cargoes with little perturbation of soluble cargoes
following dynasore treatment.

Fluorescence loss in photobleaching
INS-1 HID-1 KO cells stably expressing HID-1-GFP or G2A-GFP were transfected
with sialyltransferase-pTAG-RFP657 using FuGene. The following day, transfected cells
were plated on poly-L-lysine coated coverslips. Two days after transfection, coverslips
were placed in an open imaging chamber (Thermofisher) and imaged using an Olympus
Fluoview scanning confocal microscope and a 63× oil objective (NA 1.42) at a resolution
of 512 × 512 pixels with a sampling speed of 8.0 μs/pixel with Kalman filter (integration
count 5). Cells were bleached for ~1sec at 100% laser output and imaged followed by a
15sec recovery period. Movies were taken for a total of 5min. Analysis of fluorescence
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intensity was restricted to the Golgi area by using the sialyltransferase-pTAG-RFP657 to
generate an ROI within ImageJ.

Spinning disk confocal live imaging
PC12 cells were co-transfected with NPY-pHluorin or VMAT2-pHluorin together with
BDNF-mCherry. At 1 d after transfection, cells were transferred to poly-l-lysine coated 22
mm glass coverslips. After an additional 2 d, cells were washed once with Tyrode’s buffer
and coverslips were transferred to an open imaging chamber (Life Technologies). Cells
were imaged close to the coverslips, focusing on the plasma membrane (determined by the
presence of BDNF-mCherry positive plasma membrane docked-vesicles), using a custombuilt Nikon spinning disk at a resolution of 512 × 512 pixels. Images were collected for
100 ms at 10 Hz at room temperature with a 63× objective (Oil Plan Apo NA 1.49) and an
ImageEM X2 EM-CCD camera (Hamamatsu, Japan). Following baseline data collection
(15 s), an equal volume of Tyrode’s buffer containing 90 mM KCl was added to stimulate
secretion and cells were imaged for an additional 30 s. At the end of the experiment, cells
were incubated with Tyrode’s solution containing 50 mM NH4Cl, pH 7.4, to reveal total
fluorescence and to confirm that the imaged cells were indeed transfected. Movies were
acquired in MicroManager (UCSF) and exported as tif files. To automatically detect newly
appearing exocytic events within a cell, difference images were constructed between the
averages of adjacent pairs of frames in a given movie, that is, mean (n + 2, n + 3) – mean
(n, n + 1), where n is any frame between the first and last frame minus 3. Positive
differences in intensity between the averaged frames were taken to be candidate events.
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The difference images were then passed through a Gaussian filter to reduce image noise.
Transfected cells were cropped from each movie by hand and analyzed individually. Event
detection was performed using a wavelet-based method as previously described
(OlivoMarin, 2002; Jaqaman et al., 2008). Noise events were filtered from the true events
on the basis of intensity and the stipulation that events occur within the confines of the cell,
and not overlap with previously counted events. A convex hull around the remaining events
was generated to approximate cell area and to find the density of events. Cell activity could
then be assessed by producing the cumulative sum of events produced by a cell over the
course of the movie. All image analysis was performed using MATLAB and the MATLAB
image processing toolbox.

Density gradient centrifugation
Density gradient fractionation Equilibrium sedimentation through sucrose was
performed as previously described (Asensio et al., 2010, 2013). Briefly, a postnuclear
supernatant was prepared from PC12 cells by homogenization with a ball bearing device
(12 µm clearance), loaded onto a 0.6–1.6 M continuous sucrose gradient, and sedimented
at 30,000 rpm in an SW41 rotor for 14–16 h at 4°C. Fractions (∼750 µl each) were collected
from the top and were analyzed by quantitative fluorescence immunoblotting using an FX
Imager (BioRad) or a FluoChem R (ProteinSimple). Velocity sedimentation through
sucrose was performed as described above, with postnuclear supernatant loaded onto a 0.3–
1.2 M continuous sucrose gradient and sedimented at 25,000 rpm for 19 min. Fractions (1
ml) were collected from the top and analyzed as above.
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Electron microscopy
PC12 cells were plated onto Aclar film disks coated with poly-l-lysine, fixed with 2.5%
glutaraldehyde, 2% paraformaldehyde, and 2 mM calcium chloride in 0.15 M cacodylate
buffer (pH 7.4). Coverslips were rinsed and fixed in a mixture of 2.5% glutaraldehyde and
2% paraformaldehyde in 0.15 M cacodylate buffer at pH 7.4 with 2 mM calcium chloride
warmed to 37°C for 5 min in an incubator. Subsequently, samples were transferred to a
refrigerator at 4°C in the same fixative solution until they were ready to be processed. Once
ready to be processed, each coverslip was rinsed in 0.15 M cacodylate buffer three times
for 10 min each and subjected to a secondary fixation step for 1 h in 1% osmium
tetroxide/0.3% potassium ferrocyanide in cacodylate buffer on ice. Following this, samples
were washed in ultrapure water three times for 10 min each and stained en bloc for 1 h with
2% aqueous uranyl acetate. After staining was complete, samples were briefly washed in
ultrapure water, dehydrated in a graded acetone series (50%, 70%, 90%, 100%, 100%) for
10 min in each step, infiltrated with microwave assistance (Pelco BioWave Pro, Redding,
CA) into LX112 resin, and flat embedded between two slides that had been coated with
PTFE release agent (Miller-Stephenson MS-143XD; Danbury, CT). Samples were cured
in an oven at 60°C for 48 h. Once the resin was cured, the slides were separated and the
Aclar coverslips were peeled off. A small region was excised and glued onto a blank stub
with epoxy. Thin sections (70 nm) were taken and imaged on an FE-SEM (Zeiss
Crossbeam 540, Oberkochen, Germany) using the aSTEM detector. The SEM was
operated at 28 KeV and probe current 0.9 nA, and the STEM detector was operated with
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the annular rings inverted for additional image contrast. Whole cells were imaged at 6114
× 4608 pixels with a resolution of 3.722 nm/pixel from random sections. Zoomed regions
were imaged at 2048 × 1536 pixels with a resolution of 1.861 nm/pixel. Images were
analyzed with ImageJ. Morphologically identifiable LDCVs were counted per cell section
and performed blind to the conditions of the experiments.

Lysosomal inhibition
PC12 cells were incubated for 24 h in complete medium supplemented with vehicle or
a cocktail of lysosomal protease inhibitors (Sigma) including 10 μM antipain, 10 μM
leupeptin, and 5 μM pepstatin A. Cells were washed on ice with cold PBS and lysed by the
addition of 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Triton X-100, and SIGMAFAST
protease inhibitor cocktail (Sigma-Aldrich) plus 10 mM EDTA and 1 mM PMSF. Samples
were analyzed by quantitative fluorescence immunoblotting.

EGF degradation assay
WT and HID-1 KO PC12 cells were washed twice with PBS and starved of serum for
2 h in DMEM with 0.1% BSA (GoldBio). During starvation, EGF-biotin (GoldBio)
streptavidin-647 conjugate was prepared. EGF-biotin (5 μg/ml) was incubated for 30 min
at 4°C at a 5:1 ratio to streptavidin-Alexa647 (Life Technologies). Following starvation,
cells were washed twice with ice-cold PBS on ice and incubated with EGF-A647 conjugate
at a final concentration of 100 ng/ml for 1 h on ice. Excess unbound EGF was removed by
washing with ice cold PBS with 0.5% BSA. Cells were chased for indicated times before
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fixation with 4% PFA in PBS for 20 min at room temperature. Cells were analyzed by flow
cytometry (CyAn ADP Analyzer, Beckman Coulter, USA) or by scanning confocal
microscopy.

pH imaging
PC12 cells were transfected with TGN-pHluorin. At 1 d after transfection, cells were
transferred to poly-l-lysine–coated 22-mm glass coverslips. After an additional 2 d, cells
were washed once with Tyrode’s buffer (pH 7.4) and imaged using a Zeiss Axiovert
5100TV widefield microscope. Images were collected with 100 ms exposure at a resolution
of 512 × 512 pixels at room temperature with a 40× objective (NA 1.30) and a CoolSNAP
HQ2 camera (Photometrics, USA). Cells were then perfused with enriched KCl buffer
supplemented with 5 μM nigericin (Sigma-Aldrich) and 5 nM monensin (Sigma-Aldrich)
at pH 8.5 and incubated for 10 min before image acquisition. This process was repeated in
pH increments of 0.5 down to pH 5.5. For the V-ATPase inhibition experiments, cells were
perfused with Tyrode’s buffer (pH 7.4) supplemented with 200 nM BafA1 (Sigma Aldrich)
and imaged for the indicated amount of time before the generation of the calibration curve
as described above.

Quantitative PCR
RNA was isolated from HID-1 KO or WT PC12 cells with the E.Z.N.A total RNA
isolation kit (Omega); then isolated RNA was DNase treated with Turbo DNAse (Ambion).
A quantity of 2 μg of total RNA was reverse transcribed (SuperScriptIV, Thermo) and
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subjected to triplicate qPCR for the last exon–exon junction of ActB and SgII transcripts.
qPCR was performed using SYBR Green qPCR Master Mix (BioRad) and a BioRad iQ5
real-time PCR machine (BioRad) with gene-specific primers. The results were normalized
to

expression

of

the

housekeeping

CCTACTTGAGAAGGAATTTGC
ACCAACCCATTTGGTTTCTC
CCTAGCACCATGAAGATCAA

gene
SgII
ActB
ActB

ActB.

SgII

forward

primer:

Reverse

primer:

Forward

primer:

Reverse

primer:

GATAGAGCCACCAATCCAC.

BioID2
INS-1 stable cell lines were generated by transducing with soluble BioID2, HID-1BioID2, or HID-1-13x linker-BioID2 using lentivirus. Stable cell lines were grown in
2x15cm culture dishes in biotin free INS-1 media and allowed to grow to ~80% confluency.
The day before the experiment, 50uM biotin was added in fresh media to the cells. On the
day of the experiment, cells were dislodged from plates using PBS and centrifuged at 500xg
for 5min. Cells were then lysed on ice for 10min in a buffer containing 2M urea, 50mM
tris (pH8), 200mM NaCl, 0.1% SDS, 0.1% sodium deoxycholate, 1% triton-X, 1mM
EDTA, PMSF, and SigmaFast protease inhibitors, and were then briefly sonicated for 20
pulses. Lysates were centrifuged for 8min at 18,000xg at 4C and incubated with
streptavidin MyOne beads overnight at 4C with gentle agitation. The following day, beads
were washed for 3min with gentle agitation 2X with a buffer containing 150mM NaCl,
25mM tris (pH7.4). Biotinylated proteins were eluted from the streptavidin beads with an
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elution buffer containing 95% formamide, 10mM EDTA for 10min at 90C. Elutions were
analyzed by western blotting and subsequently analyzed by mass spectroscopy.
BioID sample preparation for mass spectrometry was performed as previously
described (45). In brief, proteins captured in BioID experiments were precipitated with
insulin, deoxycholate and trichloroacetic acid. Protein pellets were washed with acetone,
air dried and stored at -80C. Proteins were then solubilized, reduced and alkylated with 4%
(w/v) sodium dodecyl sulfate, 10mM tris(2-carboxyethyl)phosphine, 40mM 2chloroacetamide in 0.1M Tris pH 8.5, then diluted 10-fold into 8M Urea, 0.1M Tris pH
8.5. Samples were then applied to a 30kD molecular weight cutoff ultrafiltration device
(Millipore) and concentrated in a table top centrifuge, washed three time with 8M urea and
three times with 2M urea, all with 0.1M Tris pH 8.5. LysC (Wako) was added and samples
were incubated rocking at ambient for 2 hours, then trypsin was added and incubated
rocking at ambient overnight. Digested peptides were captured in a fresh tube using
centrifugation and buffer and urea were removed using a C-18 spin column (Pierce)
according to the manufacturer instructions. Peptides ready for LC/MS were dissolved into
5% acetonitrile with 0.1% trifluoroacetic acid and loaded directly onto the LC column
(Waters M-class BEH 1.7um C18), and separated at 300nL/minute (Waters M-class UPLC)
then detected with an Orbitrap Fusion mass spectrometer (Thermo Scientific). Rawfiles
were processed using ProteomeDiscover 1.4 (Thermo Scientific) using Mascot v2.5,
searching the human database with the fixed modification cysteine carbamidomethylation
and variable modifications methionine oxidation and protein N-terminal acetylation. All
peptides were thresholded at 1% false discovery.
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Insect cell culture
Insect cell lines Sf-9 and Tni (High Five) commercially available from Expression
Systems were maintained in ESF 921 (Expression Systems) media with continuous shaking
at 192 rpm at 27℃.

Baculovirus
The Bac-to-Bac system (Invitrogen) was used to produce the recombinant virus as
described by the manufacturer using pFastbac vector. Baculovirus was generated by
transient transfection in Sf-9 insect cells at 0.9x106 cell/mL using FuGene (Promega). P0
was collected after 72 hours and P1 was generated by infecting 1x106 Sf-9 cells/mL with
1% of P0 for 72 hours. P1 baculovirus stocks were clarified by centrifugation and stored at
4℃.

Recombinant HID-1 WT and HID-1-G2A expression and purification
High-Five cells at 2x106 cells/mL were infected with P1 baculovirus at 1:100 for
45 hrs shaking at 192 rpm at 27℃. Cultures were harvested at 1,000 g at 4℃ for 10 min.
The cell pellet was then washed with 1X PBS and spun again. The cell pellet was then
resuspended in lysis buffer at 5mL per 100mL of culture; 50mM Tris pH8, 300mM NaCl,
1mM β-mercaptoethanol, 1mM PMSF, and SIGMAFAST protease inhibitor cocktail
(Sigma-Aldrich). The suspension was then sonicated. Post-sonication 100mM NaCO3 was
added and the lysate was incubated at 4℃ for 30mins on a nutator. The lysate was spun at
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100,000 g for 25 mins at 4℃. The supernatant was separated and filtered with a 1m filter.
As the addition of NaCO3 raises the pH to 9, pH of supernatant was reduced to 8 and Tris
concentration was increased to 150mM before incubation with beads. Streptactin-XT beads
(IBA) were used at a ratio of 100uL per 100mL of culture. The supernatant was added to
the beads on a gravity column and then washed with 20mL of lysis buffer. The beads were
eluted with 50mM Biotin in lysis buffer, pH 8.5.

Recombinant protein expression and purification in bacteria
HID-1-365-551-MBP was expressed in BL21 E.Coli cells. Cells were grown to an
optical density between 0.7 and 0.8. Expression was then induced with 1mM isopropyl βD-1-thiogalactopyranoside (IPTG) overnight at 18℃. After 12-16h the cells were
harvested by centrifugation at 6,000 g at 4℃ for 10 min. The cell pellet was then
resuspended in lysis buffer at 5mL per 100mL of culture; 50mM Tris pH8, 300mM NaCl,
1mM β-mercaptoethanol, 1mM PMSF, and SIGMAFAST protease inhibitor cocktail. The
suspension was then sonicated. Post-sonication 100mM NaCO3 was added and the lysate
was incubated at 4℃ for 30mins on a nutator. Then the lysate was spun at 100,000 g for
25 mins at 4℃. The supernatant was separated and filtered with a 1.0um filter. As the
addition of NaCO3 raises the pH to 9, pH of supernatant was reduced to 8 and Tris
concentration was increased to 150mM before incubation with beads. Amylose resin
(NEB) was used at a ratio of 100uL of beads per 100mL of culture. Beads were added to
the supernatant and incubated batch style on a nutator at 4℃ for 1h. The beads and lysate
were then poured onto a gravity column were the beads were washed with 20mL of lysis
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buffer. The beads were eluted with 100mM maltose in lysis buffer for 15 mins per elution.
HID-1-682-788-MBP was expressed and purified using a similar protocol with omission
of the NaCO3 step.

Liposome Preparation
Lipid stocks in chloroform were received from Avanti Polar Lipids: DOPC
(850573), POPC (850475), PI(4)P (840045). The lipid mixtures were dried under vacuum
for 1h at molar percentages of POPC (20%), DOPC (80%) or POPC (20%), DOPC (78%),
and PI(4)P (2%). They were then resuspended in 50mM Tris pH8 and 150mM NaCl buffer
at a concentration of 1ug/ul at incubated at room temperature for 1 hour. The lipid mixture
was then extruded through either a 1µm or a 0.1µm filter a total of 25 times.

Liposome Flotation Assay
Polycarbonate tubes were siliconized with Sigmacote (Sigma Aldrich) and washed
with water prior to use. 75µl of the extruded liposomes was mixed with 25µL of protein at
a concentration of 0.5µM for the binding step and was desalted into a buffer of 50mM Tris
pH8 and 150mM NaCl prior to incubation. The liposomes and protein mixture were then
incubated at room temperature for 30min. 100uL of 60% sucrose in 50mM Tris pH8 and
150mM NaCl was added to the liposome/protein mixture to create a layer of 30% sucrose.
250µL of 25% sucrose was gently layered on top followed by 50µL of buffer. The sucrose
gradient was then spun at 180,000g for 1h at 20℃ in a TLS 55 swinging bucket rotor. 50µL
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of the top fraction was taken and mixed with sample buffer. On an SDS-Page gel, 10% of
the top fraction and 10% of the protein input were ran for quantification.

Recombinant protein pulldown assay
WT PC12 cells were spun down at 300g for 5 minutes and were flash frozen with
liquid nitrogen. The cell pellet was then lysed in 50mM Tris pH 8, 150mM NaCl, 1%
TritonX-100, 1% NP-40, 0.5% SDS, with 1mM PMSF and SIGMAFAST protease
inhibitor cocktail added. Lysate was spun at 21,000 g for 10min at 4℃. The supernatant
was harvested, and protein concentration was measured.
For full-length WT HID-1 and G2A-HID-1 pulldowns, recombinant proteins were
desalted into 50mM Tris pH8 and 150mM NaCl. 30µg of protein was loaded onto 20µL of
Strep-Tactin XT beads and incubated for 1 hour at room temperature. A control using only
20µL of Strep-Tactin XT beads with no protein bound was done simultaneously. The beads
were pelleted at 300g for 5 min, the protein mixture was removed, and 1mg of PC12 lysate
was added to the beads. The lysate was incubated with the beads for 1 hour at 4℃. The
beads were pelleted again and washed with 150mM Tris pH8 and 150mM NaCl for 5 mins
at room temperature for a total of three times. The beads were then eluted with 50µL of
sample buffer, boiling at 100℃ for 5 minutes.
For HID-1-365-551, 40µL of beads from the protein prep were taken prior to
maltose and incubated with 500µg of PC12 lysate as indicated above. As a negative control
MBP only was used.
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Size Exclusion Chromatography and MALS
Protein elutions up to a volume of 500µL were loaded into a Fast Protein Liquid
Chromatography (Akta) system and run through a Superdex 200 Inc (10/300) GL column
at a rate of 0.75 mL/min using a degassed buffer composed of 50mM Tris pH8 and 150mM
NaCl filtered at 0.22µm. The FPLC was connected to a miniDAWN Treos Multi-Angle
Light Scattering device (Wyatt) to determine molecular mass and polydispersity.

Circular dichroism (CD)
CD spectroscopy was performed to evaluate the secondary structure of WT and
G2A HID-1 using a Jasco J-1000 spectropolarimeter (Jasco). The protein was used at
0.28mg/mL in 50mM Tris pH8 and 150mM NaCl in a volume of 200 µl in a cuvette with
1 mm path length. Spectra were recorded from 200-260 nm. The parameters were as
follows: 1 nm data pitch, digital integration time of 1 s, 1 nm bandwidth, 100 nm/min
scanning speed, and three repeats for each measurement. Blank measurements without
protein were subtracted from the spectra before analysis.

Statistics
Unless indicated otherwise, all statistical analysis was performed using the twotailed Student’s t test. Statistical analyses were conducted using Excel or Prism.
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Figure preparation
Images were processed using ImageJ; any changes in brightness and contrast were
identical between samples meant for comparison.
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Chapter Three: Differential sorting behavior for soluble and transmembrane cargoes at the trans-Golgi network in endocrine cells
This chapter was adapted from the Hummer et al (2019) (Hummer et al., 2019)
publication in MBoC for the purposes of this dissertation.

Introduction
One of the main limitations to address this problem comes from the lack of sensitive
approaches to evaluate sorting into pathways originating at the TGN. In the past, an elegant
budding assay that relies on protein sulfation at the TGN has been used to demonstrate the
specific sorting of proteins into nascent LDCVs (Tooze and Huttner, 1990). However, this
assay is limited to the analysis of soluble LDCV cargo proteins that are both highly
abundant and sulfated. It has therefore not been possible to monitor emergence from the
TGN of lower abundance proteins, in particular integral membrane proteins, that are
presumably not sulfated.

Results
Visualization of LDCV formation using RUSH
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In order to synchronize and visualize the movement of cargoes along the secretory
pathway in (neuro-)endocrine cells, we used the RUSH system (Boncompain et al., 2012).
To test whether this approach could be applied to study the formation of LDCVs from
(neuro-)endocrine cells, we began by determining the behavior of soluble LDCV cargoes.
For this, we relied on neuropeptide Y (NPY) and SgII as their respective fusion to emdGFP
(or other fluorescent proteins) targets properly to LDCVs in various (neuro-)endocrine cells
including INS-1 and PC12 cells that we are using for this study (Gandasi et al., 2015,
Taraska et al., 2003, Courel et al., 2008). We fused emdGFP-SBP to the C-terminus of
NPY (Fig. S1A) and transfected INS-1 and PC12 cells with optimized hook and cargo
(NPY-emdGFP-SBP) plasmids together with a TGN marker (sialyltransferaseTagRFP657). As a first step, we validated that our cargo trafficked properly through the
secretory pathway. In absence of biotin, the reporter was found diffused across the cell,
consistent with an ER localization, and treatment of cells with biotin led to its redistribution
as expected. At 30 min, we observed strong localization at the TGN and following that
time point the majority of the signal could be found in post-TGN vesicular carriers (Fig.
3A; Fig. S1B). After 1h of biotin treatment, NPY-emdGFP-SBP accumulated in discrete
punctate structures that co-localized with endogenous insulin in INS-1 cells or endogenous
SgII in PC12 cells (Fig. 3B; Fig. 5B, D; Fig. S1C). Similarly, SgII-emdGFP-SBP (Fig.
S1A) co-localized with insulin in INS-1 cells (Fig. 5G). We also determined the steadystate distribution of the reporters after incubating our cells with biotin for 24h. NPYemdGFP-SBP accumulated in LDCVs found at the tip of processes and colocalized with
endogenous insulin (for INS-1 cells) or endogenous SgII (for PC12 cells). We also
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Figure 3. Visualization of LDCV formation using RUSH.
(A) INS-1 cells were transfected with NPY-emdGFP-SBP together with the TGN marker
sialyltransferase-TagRFP657 and ER-hook, incubated with biotin for the indicated times,
fixed and imaged using a widefield epifluorescence microscope. (B) INS-1 cells
transfected with RUSH constructs were incubated with biotin for 1h or 24h, fixed and
immunostained for insulin followed by Alexa Fluor 647-conjugated secondary antibodies.
Cells were imaged by spinning-disk confocal microscopy. Insets denoted by a square are
shown in B’. INS-1 (C, D) or PC12 cells (E) were transfected with NPY-emdGFP-SBP
and ER hook for secretion assays. Cells were incubated with biotin for 1.5h (C, E) or 3h
(D) followed by exposure to basal or stimulated conditions for 15min. Secretion was
determined by reading the fluorescence in the media and was normalized to total
fluorescence in cell lysate. *p < 0.05, ****p < 0.0001 relative to NPY basal (for INS-1
cells 1.5h n = 3, for INS-1 cells 3h n = 4, for PC12 cells n =3) by unpaired two-tailed ttest. Data shown indicate mean ± SEM. Scale bars indicate 10 μm and 1 μm for insets.
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confirmed that NPY-emdGFP-SBP expressed as a full-length protein in both INS-1 and
PC12 cells by western blot and found lower molecular bands in INS-1 cells indicative of
processing (Fig. S1D). These data suggest that these professional secretory cells are able
to sort cargoes efficiently even under artificial conditions leading to a large wave of
cargoes.
The ability to store LDCV cargo and release it under stimulatory conditions is a
defining feature of (neuro-)endocrine cells. To further assess the functionality of our
cargoes, we performed a secretion assay following RUSH. Working with INS-1 cells at
first, we tested whether we could stimulate the release of NPY-emdGFP-SBP from newly
formed LDCVs. Although we did not observe significant stimulation at 1.5h post biotin
(Fig. 3C), the amount of NPY-emdGFP-SBP and SgII-emdGFP-SBP secreted in response
to depolarization (high K+) more than doubled at 3h post biotin (Fig. 3D). We next
performed experiments in PC12 cells and found that, under basal conditions, these cells
secreted ~5% of total NPY-emdGFP-SBP; depolarization stimulated the release of NPYemdGFP-SBP (~9 fold) at 1.5h post biotin (Fig. 3E). Altogether these data suggest that our
cargoes sort efficiently to the RSP. The data also indicate that LDCVs from PC12 cells
become competent for regulated release faster than insulin LDCVs from INS-1 cells.

Determination of soluble and transmembrane LDCV cargo TGN budding kinetics
In order to visualize cargo movement along the secretory pathway, we imaged INS1 cells expressing NPY-emdGFP-SBP or SgII-emdGFP-SBP live following the addition
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of biotin and observed a wave of fluorescent cargo entering the TGN labeled with
sialyltransferase-TagRFP657. After reaching a peak, TGN fluorescence decreased
concomitantly with the formation of post-TGN carriers. We determined the ER exit rate
constant (kER) by measuring the fluorescence change within the ER and fitting the data to
a first-order decay curve. Next, we monitored the decrease in fluorescence at the TGN and
fitted the data to extrapolate the TGN exit rate constant (kTGN). Both constructs exited the
ER at similar rates but NPY-emdGFP-SBP exited the TGN slightly faster than SgIIemdGFP-SBP (Fig. 4). These data suggest that the trafficking rate through different
organelles varies between cargoes.
Next, we tested whether RUSH could be applied to study budding kinetics of
LDCV transmembrane protein cargoes. For this, we relied on phogrin and VMAT2 (Fig.
S1A), which both target efficiently to LDCVs in both INS-1 and PC12 cells (Taraska et
al., 2003, Tsuboi et al., 2000, Asensio et al., 2010, Liu et al., 1994). By western blot, we
found that phogrin-emdGFP-SBP expressed as a full-length protein in both INS-1 and
PC12 cells and observed lower molecular bands in INS-1 cells indicative of processing
(Fig. S1D). In absence of biotin, phogrin-emdGFP-SBP was found diffused across the cell,
consistent with an ER localization, and treatment of cells with biotin led to its redistribution
as expected. At 40 min, we observed strong localization at the TGN and following that
time point the majority of the signal could be found in post-TGN vesicular carriers (Fig.
S2A). Live imaging experiments in INS-1 cells revealed that phogrin-emdGFP-SBP and
VMAT2-emdGFP-SBP exited the ER with similar kinetics, which were slower than the
ones measured for soluble regulated LDCV cargoes. Phogrin-emdGFP-SBP
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Figure 4. Determination of soluble and transmembrane LDCV cargo TGN budding
kinetics.
INS-1 cells were transfected as in Fig. 1 with the indicated cargoes. Fluorescence within
the TGN region (A) and the ER (B) was monitored and the data were fitted using a firstorder kinetic model to extrapolate ER (kER) and TGN rate constants (C). Representative
curves are shown for each cargo. (n=16 for NPY-emdGFP-SBP from 3 independent
transfections; n=8 for SgII-emdGFP-SBP from 2 independent transfections; n=14 for
phogrin-emdGFP-SBP from 3 independent transfections; n=11 for VMAT2-emdGFP-SBP
from 2 independent transfections).
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exited the TGN with similar kinetics than SgII-emdGFP-SBP, and VMAT2-emdGFP-SBP
budding rate was significantly slower (Fig. 4). Importantly, our imaging conditions led to
minimal photobleaching (Fig. S2B, C). Our data illustrate that secretory cargoes exit the
TGN at specific rates with soluble LDCV cargoes tending to traffic faster than
transmembrane LDCV cargoes.

Transmembrane LDCV cargoes do not exit the TGN within LDCVs but get recruited
later.
Surprisingly, when looking at phogrin-emdGFP-SBP and VMAT2-emdGFP-SBP
localization after 1h of biotin, we found that they did not colocalize with insulin unlike
NPY-emdGFP-SBP and SgII-emdGFP-SBP (Fig. 5). However, we observed robust
accumulation at the tip of processes after 24 h of biotin treatment, suggesting that these
fusion proteins eventually traffic properly (Fig. 5). Time course experiments revealed that
the enrichment within insulin granules increases gradually to peak at around 8h post biotin
(Fig. S2D). In addition, we obtained similar results after pulsing our cells with biotin for
30min followed by extensive washes to enable hooking of cargo synthesized after the initial
wave (Fig. S2E). This indicates that continuous synthesis of cargo happening after the
initial release of the hooked cargo is not responsible for the increase in colocalization
observed at later time points. These data suggest that, at least using this approach, phogrinemdGFP-SBP and VMAT2-emdGFP-SBP might exit the TGN within non-regulated
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Figure 5. Transmembrane LDCV cargoes do not exit the TGN within LDCVs but get
recruited later.
INS-1 cells were transfected with phogrin-emdGFP-SBP (A) or SBP-emdGFP-VSV-G (B)
and incubated with biotin as in Fig. 1. (A) INS-1 cells were co-stained for insulin at 1h or
24h. Insets denoted by a square are shown in A’ and C’. The extent of colocalization with
insulin was determined by Manders Correlation Coefficient (MCC) at 1h (B) and 24h (D).
MCC was also calculated for NPY-emdGFP-SBP for comparison using the images shown
in Fig. 1. *p<0.05; ****p<0.0001 by one-way ANOVA followed by posthoc Tukey t-test
(for SBP-emdGFP-VSV-G 1hr Biotin: n = 21 cells from 2 independent transfections; for
SBP-emdGFP-VSV-G 24h biotin: n = 28 from 3 independent transfections for phogrinemdGFP-SBP 1hr Biotin: n = 21 cells from 2 independent transfections; for phogrinemdGFP-SBP 24h biotin: n = 28 from 3 independent transfections, for NPY-emdGFP-SBP
1h biotin: n = 26 cells; for NPY-emdGFP-SBP 24h biotin: n = 29 cells). (E-H) INS-1 cells
were transfected with VMAT2-emdGFP-SBP (E) or SgII-emdGFP-SBP (G) and costained for insulin at 1h or 24h. Insets denoted by a square are shown in E’ and G’. The
extent of colocalization with insulin was determined by Manders Correlation Coefficient
(MCC) at 1h and 24h for VMAT2-emdGFP-SBP (F) and SgII-emdGFP-SBP (G). *p<0.05,
****p<0.0001 by unpaired t-test (for VMAT2-emdGFP-VSV-G 1hr biotin: n = 21 cells,
24h biotin: n=12 cells from 2 independent transfections; for SgII-emdGFP-SBP 1h biotin:
n=24 cells, 24h biotin: n = 22 cells from 3 independent transfections). Data shown indicate
mean ± SEM. Scale bar indicates 10 μm and 1μm for insets.
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vesicles, likely constitutive secretory carriers, and get incorporated to LDCVs only later,
possibly during LDCV maturation.
To test this hypothesis more directly, we repeated the experiments in presence of the
dynamin inhibitor dynasore in INS-1 cells. Indeed, dynamin II mediates the scission of
constitutive secretory vesicles at the TGN (Jones et al., 1998, Kockx et al., 2014). As a
positive control, we looked at the behavior of a bona fide transmembrane marker of
constitutive secretory vesicles, SBP-emdGFP-VSV-G (Fig. S1A) (Rivas and Moore,
1989). We first validated that SBP-emdGFP-VSV-G trafficked properly through the
secretory pathway (Fig. 5B). Indeed, after 1h of biotin, we could observe accumulation of
this marker at the plasma membrane as expected, suggesting that it is reaching the cell
surface in a constitutive manner and it did not colocalize with insulin at 1h or 24h (Fig.
5B-D). Dynasore treatment led to accumulation of SBP-emdGFP-VSV-G in the TGN
region and slowed down its budding kinetics (Fig. 6A, B). As a consequence, we could not
detect post-TGN carriers in cells treated with dynasore post peak, whereas they were
readily detectable in vehicle-treated cells (Fig. 6A’ arrows). In contrast, dynasore treatment
slowed down budding of NPY-emdGFP-SBP to a lesser extent (Fig. 6C, D). As a
consequence, we could still observe budded LDCVs in presence of the inhibitor (Fig. 6C’).
Next, we performed the same experiments with phogrin-emdGFP-SBP and VMAT2emdGFP-SBP and observed that dynasore treatment prevented budding from the TGN of
both cargoes (Fig. 6E, F; Fig. S2F). These data suggest that transmembrane LDCV cargoes
exit the TGN within non-regulated secretory vesicles.

55

56

Figure 6. Dynamin II inhibition inhibits constitutive vesicle budding but not LDCV
formation.
INS-1 cells transfected with the indicated cargoes were incubated with biotin in presence
or absence of 80μM dynasore. Fluorescence within the TGN region was monitored as
described in Fig. 2A. Insets are shown in A’, C’ and E’. Arrows indicate post-TGN carriers.
Average curves of TGN fluorescence are shown in (B), (D) and (F). (n=9 and 9 cells from
2 independent transfections for SBP-emdGFP-VSV-G vehicle and dynasore, respectively;
n=19 and 20 cells from independent transfections for NPY-emdGFP-SBP vehicle and
dynasore, respectively; n=7 and 12 cells from 3 independent transfections for phogrinemdGFP-SBP vehicle and dynasore, respectively). Data shown indicate mean ± SEM.
Scale bar indicates 10μm and 1μm for insets.
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Simultaneous visualization of constitutive and regulated secretory cargo budding
from TGN
In order to further distinguish sorting of cargoes to the constitutive and regulated
secretory pathways, we next tested whether we could follow two cargoes simultaneously.
For this, we generated NPY-mCherry-SBP that we co-expressed with SgII-emdGFP-SBP,
phogrin-emdGFP-SBP or SBP-emdGFP-VSV-G. To visualize budding from the TGN, we
imaged our cells after 40 min of biotin treatment in order to get a wave of cargoes to the
TGN. To our knowledge, this represents the first successful attempt at simultaneously
imaging cargo sorting to constitutive vs regulated secretory pathways in real-time. When
looking at two soluble regulated secretory cargoes, the majority of budding vesicles
contained both NPY-mCherry-SBP and SgII-emdGFP-SBP (Fig. 7A-C). On the other
hand, we observed significantly less NPY-mCherry-SBP vesicles being positive for SBPemdGFP-VSV-G (Fig. 7B, C), as expected for two cargoes known to traffic to the
regulated and constitutive secretory pathway, respectively. Interestingly, the proportion of
NPY-mCherry-SBP vesicles also positive for phogrin-emdGFP-SBP was similar to SBPemdGFP-VSV-G (Fig. 7B, C), indicating again that phogrin exits the TGN within nonregulated secretory vesicles.
Finally, we repeated the same experiment in presence of dynasore to block or slow
down vesicle budding from the TGN. The treatment impeded vesicular movement of all
studied cargoes, but the effect seemed more pronounced for SBP-emdGFP-VSV-G and
phogrin-emdGFP-SBP, resulting in a more arrested distribution around the Golgi area.
NPY-mCherry-SBP did not colocalize with these arrested vesicles, whereas it did
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Figure 7. Simultaneous visualization of constitutive and regulated secretory cargo
budding from the TGN.
(A-C) INS-1 cells co-transfected with NPY-mCherry-SBP and indicated emdGFP-RUSH
constructs as in Fig. 2 and imaged every 300ms for 2min after 40min of biotin treatment.
The proportion of vesicles positive for both markers was determined (A, B). ****p <
0.0001 (n=14 cells for SgII-emdGFP-SBP, n=12 for phogrin-emdGFP-SBP, n=19 for SBPemdGFP-VSV-G from 2 independent transfections) by one-way ANOVA followed by
posthoc Tukey t-test. Data shown indicate mean ± SEM. Consecutive frames from the
movies are shown in C. (D-G) INS-1 cells co-transfected with NPY-mCherry-SBP and
indicated emdGFP-RUSH constructs as in Fig. 2 and imaged every 300ms for 2min after
40min of biotin and dynasore treatment. Consecutive frames from the movies are shown
in D. (E-G) Line-scan profiles from a single frame from a single representative movie
represent the fluorescence intensity across the TGN and its vicinity. Arrows indicate
vesicles positive for both markers; arrowheads indicate vesicles positive for one marker.
Scale bar indicates 10μm.

60

colocalize with SgII-emdGFP-SBP (Fig. 7D-G). Additionally, these soluble regulated
secretory cargoes seemed more dynamic. Altogether these results indicate that phogrinemdGFP-SBP does not exit the Golgi within vesicles containing soluble regulated
secretory cargoes and suggests that it gets added to LDCVs post-budding.

Discussion
Here we have demonstrated live trafficking through the RSP of the
neuroendocrine cell lines, INS-1 and PC12, using the RUSH system. We have accurately
quantified the budding kinetics of both soluble and transmembrane proteins within these
cell types and determined a potential new route of exit of transmembrane proteins from
the TGN. Finally, we have performed for the first time, to our knowledge, simultaneous
live imaging of both constitutive and regulated secretory cargoes leaving the TGN.
When determining the budding kinetics of various cargoes, we observed that the
trafficking rate through various organelles is cargo-dependent. The two soluble cargoes
assayed, NPY and SgII, were found to both leave the ER at a similar rate, but NPY left
the TGN more rapidly than SgII. This could be due to the fact SgII more readily
aggregates in the acidic milieu of the TGN as compared to NPY which may account for
the difference in TGN exit. Consistent with this idea, the regulated secretory cargoes
amylase and chymotrypsinogen undergo their main concentration between the ER and
cis-Golgi in pancreatic exocrine cells as opposed to the TGN (Oprins et al., 2001), further
suggesting cargo-dependent trafficking behavior.
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Additionally, we also observed that soluble cargoes tended to leave the TGN at a
faster rate than transmembrane cargoes. Intuitively, this seems logical as the relative
enrichment of soluble vs transmembrane proteins on LDCVs is biased towards soluble
cargoes by at least one or two orders of magnitude (Suckale and Solimena, 2010). It is also
possible that these cargoes get modified to various extents as they traffic through the
secretory pathway and that these protein modification steps contribute to the difference in
kinetics.
One of the most surprising and novel observations from this work was the
observation that phogrin leaves the TGN in non-RSP carriers; an observation goes against
the central dogma of LDCV cargo sorting and biogenesis. Interestingly, analysis of phogrin
recycling after exocytosis has revealed that it can reach an insulin-positive compartment
from the plasma membrane without first recycling back to the TGN (Vo et al., 2004).
Consistent with this idea, several genes typically associated with the endocytic and
retrograde pathways affect LDCV formation (Asensio et al., 2010, Asensio et al., 2013,
Sasidharan et al., 2012, Sirkis et al., 2013, Paquin et al., 2016, Topalidou et al., 2016, Zhang
et al., 2017).
This leaves the question as to how transmembrane cargoes meant for LDCVs
initially leave the Golgi and end up on LDCVs. We propose a model in which
transmembrane cargoes are initially sorted to non-regulated secretory vesicles that fuse
with the plasma membrane. Following recycling of the cargo protein (i.e., phogrin,
VMAT2) from the plasma membrane, they are then properly added to immature LDCVs,
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presumably from endosomal compartments. This suggests that a fusion step between
endosomal-derived vesicles and immature LDCVs occurs during maturation. However, we
haven’t been able to observe fusion events between vesicles containing a transmembrane
LDCV cargo and soluble LDCV cargo under our fast imaging conditions. This is likely
due to the fact that we only looked at early post-biotin time points. By focusing on later
time points, where colocalization is increased between transmembrane LDCV cargoes and
endogenous insulin, we anticipate to observe such fusion events.

Future Directions
Optimization of RUSH with novel cell lines and with a multitude of cargoes will
be an extremely interesting future endeavor. The observed variance in soluble cargo
kinetics suggest that different cargoes likely have very different TGN exit rates. It will be
interesting to see how a variety of factors affect exit kinetics such as aggregation state,
posttranslational modifications, and proteolytic processing. These variables could give
further insight into how different cargoes enter budding vesicles and if there are
subpopulations of LDCVs that have differing compositions of cargo proteins. Another
exciting possibility is analysis of trafficking in different cell lines. Here we assessed
trafficking kinetics within endocrine cells, but future work focusing on exocrine and
neuronal cell types could give further insight into how different systems modulate their
regulatory cargoes. A combined approach of comparing the same cargo protein within
different model systems will allow us to even further elucidate the potential differences in
the RSP in different secretory cell types.
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Identifying cargo proteins with unique sorting pathways to LDCVs will also be of
great interest. Phogrin showed unexpected trafficking behavior by first leaving the TGN
in non-regulated carriers but appearing on mature LDCVs after ~8hrs. This exemplifies a
separate route to LDCVs and suggests that the maturation process may be more dynamic
than once thought and that the joining of distinct membrane carriers may be an important
step in sorting and maturation of LDCVs. It will be interesting to test this hypothesis in
the future as well as determining the exact step controlling the recruitment of phogrin,
and whether this mechanism holds true for all transmembrane LDCV cargoes and will
provide invaluable information about the mechanisms controlling sorting of
transmembrane proteins.
Finally, identifying the molecular players required in budding process of LDCVs
will be critical to completely understand LDCV biogenesis. By fluorescently tagging
proteins known to be essential in the process of LDCV budding and biogenesis combined
with the powerful RUSH system, we will be able to create a more complete concept of
the interplay of all proteins involved. With this imaging approach we will be able to
characterize the temporal and spatial cascades of factors involved in LDCV budding,
which will be paramount to understanding this complex process.
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Chapter Four: HID-1 controls large dense core vesicle formation by
influencing cargo sorting and TGN acidification
This chapter was adapted from the Hummer et al (2017) (Hummer et al., 2017)
publication in MBoC for the purposes of this dissertation.

Introduction
A forward genetic screen in the model organism C. Elegans has previously
identified HID-1 as a factor implicated in neuropeptide sorting and secretion (Mesa et al.,
2011). HID-1 null worms display reduced levels of LDCV soluble cargo and impaired
neurosecretion (Mesa et al., 2011, Yu et al., 2011), and conditional KO mice lacking HID1 in beta-cells of the pancreas display a defect in insulin secretion (Du et al., 2016),
suggesting that this factor might be significant for glucose homeostasis. Interestingly, HID1 is a peripheral membrane protein associated with the Golgi/TGN and its expression seems
restricted to specialized secretory cells (Wang et al., 2011), suggesting that it might directly
contribute to LDCV biogenesis.

Results
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HID-1 is required for LDCV soluble cargo storage and secretion
To investigate a potential role for HID-1 in mammalian RSP, we generated HID-1
knockout PC12 cells using genome editing. Specifically, we relied on homologous
recombination repair after cleavage by Cas9 to knock-in a fluorescent protein (tdTomato),
while effectively knocking-out HID-1. Our repair template was designed in such a way that
the fluorescent reporter should not be expressed without proper, in-frame recombination
(Figure S3A,B). Although this approach does not guarantee bi-allelic homologous
recombination, we reasoned that, as the efficiency of Cas9-mediated cleavage is much
higher than homologous recombination repair, cells with mono-allelic recombination
would have a high probability of exhibiting indels on the other allele due to non-homology
end joining. After transfecting PC12 cells with Cas9, gRNA and our repair template, we
sorted cells positive for tdTomato by flow-cytometry. After three consecutive rounds of
cell sorting, the proportion of positive cells shifted from an initial 0.2% to greater than
90%. We further validated that our repair template was integrated at the proper locus by
performing PCR on genomic DNA isolated from our sorted cells (Figure S3C). We also
observed the existence of alleles without tdTomato suggesting that the integration is monoallelic in some cases. However, sequencing of these non-recombined alleles revealed the
presence of various indels (Figure S3D). The most common (11 out of 24) mutation that
we identified is a 47 deletion directly downstream of the cleavage site. Figure S3D lists all
the identified mutations. Importantly, the presence of the WT allele was only found on
three occasions. All the other mutations led to out-of-frame deletions or insertions (Figure
S3E). To confirm that HID-1 was indeed deleted from our cell population, we analyzed
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our cells by western blot and immunofluorescence testing commercial antibodies against
HID-1. Although we were unable to find any antibodies suitable for immunoblotting, we
identified a mouse monoclonal antibody (see Material and Methods) displaying a specific
signal by immunofluorescence (Figure 8A). Indeed, WT cells displayed a strong
perinuclear staining that was absent from HID-1 KO cells. The same signal could be
observed in HID-1 KO cells expressing HID-1-HA (Figure 8B). Consistent with our cell
sorting enrichment data, we observed that HID-1 was absent from greater than 90% of our
cells by immunofluorescence, which is consistent with our genotyping results. This
genome-editing approach offers the advantage of relying on transient expression of Cas9
and gRNAs, which should limit off-target effects.
Loss of HID-1 significantly reduced basal cellular levels of the LDCV soluble
marker SgII to ~40% of that observed in control cells by fluorescent western blot, and
impaired the stimulation of SgII release by depolarization (Figure 8C-E). However, we
found no significant reduction after normalizing secreted SgII values to total SgII levels,
suggesting that there is no impairment in regulated exocytosis per se and that the decrease
in SgII content is the major contributor to the defect in release (Figure 8F). We observed
a similar phenotype in a second HID-1 KO PC12 cell line generated using an independent
gRNA (Figure S4). Furthermore, we observed no change in SgII mRNA levels by qPCR
(Figure S5) and found a similar storage and secretion defect of a transfected, exogenous
soluble LDCV marker (ANF-GFP), whose expression is under the control of a strong CMV
promoter, suggesting that the decrease in cellular content is unlikely to be transcriptional
(Figure S6). Importantly, lentivirus-mediated expression of full-length HID-1 bearing a C67

Figure 8. Loss of HID-1 reduces LDCV cargo content and secretion.
(A) WT and HID-1 KO PC12 cells were stained with a mouse monoclonal antibody to
HID-1, followed by an anti-mouse antibody conjugated to Alexa Fluor 488 and mounted
with fluormount containing DAPI. Representative confocal micrographs show the absence
of HID-1 staining in HID-1 KO PC12 cells. (B) HID-1 KO PC12 cells transfected with
HID-1-HA were stained with a mouse monoclonal antibody to HID-1 and rat monoclonal
antibody to HA, followed by an anti-mouse antibody conjugated to Alexa Fluor 488 and
anti-rat antibody conjugated to Alexa Fluor 647. Representative confocal micrographs
show the presence of HID-1 staining only in cells expressing HID-1-HA. Scale bar
indicates 5µm. (C) PC12 cells (WT, HID-1 KO or HID-1 KO transduced with HID-1-HA
lentivirus) were washed and incubated for 30 min in Tyrode’s solution containing 2.5 mM
K+ (basal) or 90 mM K+ (stimulated). Cellular and secreted secretogranin II (SgII) were
measured by quantitative fluorescent immunoblotting (C), with the secreted SgII
normalized to tubulin (D) or total SgII (F) and expressed as percent of basal secretion in
the control, and the basal cellular SgII normalized to tubulin (E). Multiple comparison
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statistical analysis was performed by one-way ANOVA followed by posthoc Tukey test *,
p < 0.05; **, p < 0.01 relative to KO (n=4). No statistical difference was observed between
WT and KO + rescue. The bar graphs indicate mean ± s.e.m. (G) WT and HID-1 KO PC12
cells were transfected with NPY-pHluorin, then imaged live by spinning disk confocal
microscopy for 15 seconds in basal Tyrode’s solution. Regulated exocytosis was triggered
by the addition of an equal volume of 90mM K+ Tyrode’s solution (45 mM K+ final) and
imaged for an additional 30 seconds. Images show representative maximum intensity time
projections of 150 basal and stimulated frames. At the end of the experiment, cells were
imaged in Tyrode’s solution containing 50 mM NH4Cl, pH 7.4 to reveal total NPYpHluorin fluorescence by alkalinization and identify transfected cells. Scale bar indicates
5 µm. Bar graph shows the number of exocytotic events per second normalized to cell
surface area. Multiple comparison statistical analysis was performed by one-way ANOVA
followed by posthoc Tukey test **, p < 0.01 relative to stimulated exocytosis from WT
(n=15 cells for WT and n =11 cells for KO from two independent experiments).
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terminal HA-tag (HID-1-HA) in HID-1 KO cells restored SgII to WT levels and rescued
the secretion phenotype (Figure 8C-F), thus ruling out Cas9 off-target effects.
To further assess secretion of LDCV soluble cargo, we transfected WT and HID-1
KO PC12 cells with NPY fused to the superecliptic pHluorin (NPY-pHluorin), which has
been shown to undergo regulated exocytosis (Kogel et al., 2010, Sirkis et al., 2013), and
monitored individual exocytotic events by live-imaging using spinning disk confocal
microscopy (Figure 8G). As expected, WT PC12 cells displayed very few events under
basal conditions and responded to depolarization (~7 fold over basal). The number of basal
events observed in HID-1 KO cells remained low and unchanged, but we observed a
striking reduction in the amount of exocytotic events in response to stimulation in these
cells (Figure 8G). Altogether, our results suggest that the absence of HID-1 reduces
storage and secretion of LDCV cargoes.

HID-1 does not influence the endolysosomal or constitutive secretory pathway
To rule out that the impact of HID-1 KO on the RSP was due to indirect effects on
constitutive secretion or endocytosis, we analyzed secreted fractions obtained from WT
and HID-1 KO PC12 cells under non-stimulatory conditions by Coomassie (data not
shown) or by silver staining after SDS-PAGE, and observed no obvious difference in the
general pattern of constitutively secreted proteins (Figure 9A). Consistent with this, direct
quantification of the secretion of emerald GFP fused to a signal sequence (ssGFP) revealed
no change in release of this exogenous marker of the constitutive secretory pathway
(Figure 9B).
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Figure 9. Loss of HID-1 does not affect constitutive secretion or the endolysosomal
system.
(A) Constitutive secreted fractions from unstimulated cells were analyzed by silverstaining after SDS-PAGE. (B) WT and HID-1 KO PC12 cells were transiently
transfected with ssGFP, washed and incubated for 30min in basal Tyrode’s solution.
Cellular and secreted ssGFP were measured using a plate reader, with the secreted signal
normalized to cellular content (n=4). The bar graphs indicate mean ± s.e.m. (C-D) WT
and HID-1 KO PC12 cells were incubated on ice with Alexa647 labeled EGF, and chased
in complete media for the indicated time before fixation. Cells were then analyzed by
confocal microscopy (C). The scale bar indicates 5 µm. (D) Alternatively, mean
fluorescence values were quantified by flow cytometry from >10000 cells per
experiment. The data shown indicate mean ± s.e.m of three independent experiments.
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We also assessed the overall integrity of the endolysosomal pathway. For this, we
incubated WT and HID-1 KO cells with EGF labeled with Alexa647 (EGF-A647) on ice,
washed unbound EGF, and monitored the fluorescence by confocal microscopy over time
(Figure 9C). After a short chase (20 min), we observed that the majority of EGF-A647
signal was found in punctate structures near the periphery of the cells, suggesting that EGF
had undergone endocytosis. We observed no difference between WT and HID-1 KO cells.
After a longer chase (210 min), as expected, the fluorescence intensity had decreased and
was mostly found in the perinuclear region of the cells. Again, we did not observe any
striking differences between the two cell types. To better quantify EGF degradation, we
repeated the same assay and measured the change in fluorescence intensity by flow
cytometry, and found no difference between WT and HID-1 KO PC12 cells (Figure 9D).
We conclude that loss of HID-1 does not dramatically perturb the endolysosomal pathway.
Altogether, these results suggest that HID-1, which is preferentially expressed by
specialized secretory cells, specifically influences the RSP of mammalian neuroendocrine
cells.

HID-1 contributes to LDCV biogenesis by influencing TGN acidification
Our observations suggest that HID-1 might be directly involved in LDCV
biogenesis. We thus tested whether the loss of HID-1 influences the composition of
LDCVs. Relying on equilibrium sedimentation through sucrose, we found a pronounced
shift of SgII to lighter fractions (~1M sucrose compared to ~1.5M) in HID-1 KO cells
(Figure 10A). Interestingly, the loss of HID-1 also redistributed the calcium sensor
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Figure 10. Biochemical characterization of synaptic microvesicles and LDCVs in
PC12 HID-1 KO cells.
Postnuclear supernatants obtained from WT and HID-1 KO PC12 cells were separated by
equilibrium sedimentation through 0.6-1.6 M sucrose. Fractions were collected from the
top of the gradient, and assayed for secretogranin II (SgII) (A), synaptotagmin 1 (syt1) (B),
and synaptophysin (syn) (C) by quantitative fluorescent immunoblotting. The graphs
(right) quantify the immunoreactivity in each fraction expressed as a percent of total
gradient immunoreactivity from one experiment. Similar results were observed in an
additional independent experiment.
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synaptotagmin 1 away from the WT LDCV peak (bottom of the gradient) towards lighter
fractions (Figure 10B), but had no effect on the distribution of the synaptic like
microvesicle marker synaptophysin (Figure 10C). The change in the steady-state
distribution of both soluble and transmembrane LDCV markers indicates that HID-1
influences LDCV biochemical properties and might indeed contribute to biogenesis. To
complement our cell fractionation characterization, we also analyzed the cells at the
ultrastructural level by electron microscopy, and observed a substantial reduction (~70%)
in the number of distinguishable LDCVs in HID-1 KO cells (Figure 11A,B). Of note, the
few remaining LDCVs displayed a decrease in dense core size (Figure 11C), suggesting
that the observed shift in SgII density could be attributed to a decrease in the amount of
cargo per vesicle. The absence of HID-1 thus affects both the number and morphology of
LDCVs.
The presence of LDCVs with smaller and lighter dense cores could indicate a defect
in aggregation of granulogenic proteins such as the granins. The acidic environment of the
TGN lumen is thought to drive this aggregation in PC12 cells (Chanat and Huttner, 1991).
As HID-1 colocalizes with Golgi markers (Wang et al., 2011), we hypothesized that HID1 might contribute to TGN acidification. To test this directly, we targeted pHluorin to the
lumen of the TGN using the transmembrane domain of the TGN marker sialyltransferase
(Wong et al., 1992). We confirmed that our reporter indeed localizes to the TGN by
transfecting WT and HID-1 KO PC12 cells with TGN-pHluorin and comparing its steady
state localization to TGN38 by immunofluorescence (Figure 12A). Next, we used liveimaging to measure the fluorescence of our reporter expressed in WT and HID-1 KO PC12
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Figure 11. Ultrastructural analysis of PC12 HID-1 KO cells.
(A) Electron micrographs (left) show a large reduction in the number of LDCVs (black
arrowheads) in HID-1 KO PC12 cells relative to controls. Zoomed in regions (denoted with
a white square) are shown on the right and illustrate that the absence of HID-1 leads to
LDCVs with no core or dramatically reduced dense cores. The scale bar indicates 200 nm.
Bar graphs indicate the number of LDCVs per cell section (n=25 cells/WT and n=21
cells/KO) (B) and the diameter of the vesicles and cores. Data indicate the mean ± s.e.m
values of average diameter per cell (n=25 cells/WT representing a total of 1944 LDCVs
and n=21 cells/KO representing a total of 498 LDCVs obtained from two independent
experiments) (C). ***, p < 0.001 relative to WT.
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cells under basal conditions. We incubated our cells with nigericin/monensin (Wu et al.,
2000) to generate individual pH calibration curves for every cell that we imaged (Figure
12B). From the sigmoidal curves, we extrapolated absolute TGN pH values for WT and
HID-1 KO cells. Strikingly, we found that the absence of HID-1 led to a significant
alkalization of the TGN (Figure 12C). Importantly, this phenotype could be rescued by
transient expression of HID-1-HA.
How does a peripheral membrane protein such as HID-1 influence TGN pH? The
acidification of intracellular organelles depends primarily on the activity of the vacuolar
H+-ATPase (V-ATPase), which consists of two multisubunit sectors (V1 and V0). The
cytoplasmic V1 sector mediates ATP hydrolysis, whereas V0 assembles into a
transmembrane pore involved in proton translocation (Cipriano et al., 2008, Forgac, 2007,
Marshansky and Futai, 2008). PC12 cells express three isoforms (a1, a2 and a3) of the
largest V0 subunit, and each isoform displays a particular subcellular localization with
enrichment at specific organelles (Saw et al., 2011). As a2 accumulates at the Golgi in
PC12 cells, this isoform is likely to contribute significantly to Golgi acidification. Thus, in
order to test whether V-ATPases contribute to the phenotype caused by the lack of HID-1,
we looked at the distribution of a2. For this, we relied on velocity sedimentation of PC12
membranes through sucrose to separate organelles based on their size with the Golgi
migrating at the bottom of the gradient under these conditions (Asensio et al., 2010, Tooze
and Huttner, 1990). Using WT membranes, a2 displayed a bi-modal distribution with a
major peak at the bottom of the gradient, consistent with its reported Golgi localization
(Figure 12D). Strikingly, the loss of HID-1 led to a dramatic redistribution of a2 to the top
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Figure 12. Loss of HID-1 results in reduced TGN acidification.
(A) WT and HID-1 KO PC12 cells were transfected with TGN-pHluorin (green), fixed and
stained with a mouse monoclonal antibody to TGN38, followed by an anti-mouse antibody
conjugated to Alexa Fluor 647 (red). The scale bar indicates 5 µm. (B, C) WT and HID-1
KO PC12 cells were transfected with TGN-pHluorin and with HID-1-HA where indicated
(rescue), incubated for 72 hours and imaged under basal conditions. For each cell, an
individual calibration curve (B) was obtained by perfusing solutions of decreasing pH (8.5
to 5.5) in presence of nigericin and monensin (see Material and Methods) and used to
extrapolate absolute pH values (C). Statistical analysis of pH values was performed by
ANOVA followed by posthoc Tukey test *, p < 0.05; **, p < 0.01 relative to KO; (n=17
cells for WT and KO, n=13 cells for KO + rescue). The data shown indicate mean ± s.e.m.
(D) Postnuclear supernatants obtained from WT and HID-1 KO PC12 cells were separated
by velocity sedimentation through 0.3-1.2 M sucrose. Fractions were collected from the
top of the gradient and assayed for a2 by immunoblotting. The graph (bottom) quantifies
the immunoreactivity in each fraction expressed as a percent of total gradient
immunoreactivity from one experiment. Similar results were observed in an additional
independent experiment. (E) WT and HID1-1 KO PC12 cells were incubated with BafA1
(200nM) and imaged at the indicated time points. Inset shows the change in pH observed
with treatment. ***, p < 0.001 relative to KO; (n=61 WT cells and 67 KO cells from two
independent transfections plated on 6 coverslips.) The data shown indicate mean ± s.e.m.
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of the gradient away from Golgi fractions (Figure 12D). We also monitored changes in pH
following treatment with the V-ATPase inhibitor Bafilomycin A1 (BafA1) (Yoshimori et
al., 1991). Whereas BafA1 rapidly neutralized the TGN pH of WT cells, the drug had a
more modest effect in HID-1 KO cells (Figure 12E). We thus conclude that HID-1
contributes to TGN acidification by controlling the proper accumulation and/or retention
of a2 at the Golgi.
LDCV soluble cargo aggregation is thought to be a key determinant for efficient
sorting to the RSP. Indeed, treatment with drugs neutralizing intraluminal pH redirects
adrenal corticotropin hormone or granins to the constitutive secretory pathway (Gerdes et
al., 1989, Moore et al., 1983, Taupenot et al., 2005). Surprisingly, neither our biochemical
secretion experiments nor our live-imaging experiments with NPY-pHluorin (Figure 8)
revealed any increase in basal exocytosis, which would be expected from cargo being
rerouted to the constitutive secretory pathway. Then, where does the soluble cargo go?
Previous work has shown that reduced levels of LDCV soluble cargo observed in hid-1
mutant worms could be partially rescued by genetically inhibiting lysosome biogenesis (Yu
et al., 2011). To test whether increased lysosomal degradation is contributing to the
depletion of SgII observed in HID-1 KO PC12 cells, we incubated our cells with protease
inhibitors for 24 hours to inhibit lysosomal hydrolases (Asensio et al., 2013, Sirkis et al.,
2013), and found that the treatment partially rescued SgII levels in HID-1 KO cells,
suggesting that a small fraction of SgII is redirected to the lysosome in absence of HID-1
(Figure S7).
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Figure 13. Transmembrane LDCV cargoes are retained at the TGN in the absence
of HID-1.
(A) WT and HID-1 KO PC12 cells were transfected with the indicated HA-VMAT2-GFP
constructs, incubated with an HA antibody conjugated to Alexa Fluor 647 for 1 h, washed
and analyzed by flow cytometry to determine the fluorescence of individual cells. The
ratios of surface (HA) over total (GFP) were computed and expressed as a cumulative
frequency distribution. (B) WT and HID-1 KO PC12 cells were transfected with VMAT2pHluorin, then imaged live by spinning disk confocal microscopy as described in Figure
8. Images show representative maximum intensity time projections of 150 basal and
stimulated frames. At the end of the experiment, cells were imaged in Tyrode’s solution
containing 50 mM NH4Cl, pH 7.4 to reveal total VMAT2-pHluorin fluorescence by
alkalinization and identify transfected cells. Scale bar indicates 5 µm. Bar graph shows the
number of exocytotic events per second normalized to cell surface area. Statistical analysis
was performed by one-way ANOVA followed by posthoc Tukey test. **, p < 0.01 relative
to stimulated secretion from WT (n=20 cells for WT, n=16 cells for KO from two
independent experiments). The data shown indicate mean ± s.e.m. (C-E) PC12 cells were
loaded with FFN206 (a vesicular monoamine transporter fluorescent substrate) and
subjected to a secretion assay as described in Fig 1. Secreted (C) and cellular (D)
fluorescence values were measured using a plate reader. (E) Secreted FFN206 was
expressed as percent of total FFN206 fluorescence. Statistical analysis was performed by
one-way ANOVA followed by posthoc Tukey test. **, p < 0.01 relative to basal secretion
from WT; ***, p < 0.001 relative to stimulated secretion from WT (n=8). The bar graphs
indicate mean ± s.e.m. (F) WT and HID-1 KO PC12 cells were transfected with VMAT2HA, fixed and stained with HA and TGN38 antibodies followed by Alexa Fluor 488- and
Alexa Fluor 647-conjugated secondary antibodies or (G) WT and HID-1 KO PC12 cells
were transfected with TGN38-GFP, fixed and stained with Syt1 antibody followed by
Alexa Fluor 647-conjugated secondary antibody. The cells were imaged by spinning-disk
confocal microscopy. The amount of HA (F) or Syt1 (G) immunoreactivity overlapping
with TGN38 was expressed as a percent of total fluorescence. **, p < 0.001 relative to WT
(for Syt1, n=20 cells for WT and n=16 cells for KO; for VMAT2, n=26 cells for WT and
n=38 cells for KO from two independent experiments). The scale bars indicate 5µm. The
data shown indicate mean ± s.e.m.
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HID-1 influences the sorting of transmembrane LDCV cargo
Our data indicate that HID-1 influences sorting of soluble LDCV cargo by
impairing their aggregation into a dense core, but does it contribute to sorting of
transmembrane LDCV proteins as well? Similar to chromaffin cells, PC12 cells store
monoamines into LDCVs through the action of an integral membrane protein: the vesicular
monoamine transporter (VMAT), which depends on a cytoplasmic di-leucine-like motif
for sorting to LDCVs (Erickson et al., 1995; Liu et al., 1994). Mutations within this motif
cause an increase in VMAT cell surface delivery by diverting the transporter from the
regulated to the constitutive secretory pathway (Asensio et al., 2010, Li et al., 2005). To
test whether HID-1 influences sorting of VMAT, we monitored its cell surface delivery
using a flow cytometry assay that we have previously developed (Asensio et al., 2010). For
this, we transfected WT and HID-1 KO PC12 cells with HA-VMAT2-GFP, which contains
a lumenal HA tag to monitor surface level as well as a cytosolic GFP to determine total
expression. After incubating the transfected cells with an anti-HA antibody conjugated to
Alexa647, we measured GFP and Alexa647 fluorescence by flow cytometry. Cumulative
frequency distribution of the ratio of surface (HA) over total (GFP) showed no difference
between WT and HID-1 KO PC12 cells. As a positive control, we observed that WT cells
transfected with EE/AA HA-VMAT2-GFP, a trafficking mutant that missorts to the plasma
membrane (Asensio et al., 2010, Li et al., 2005), exhibited the expected shift in distribution
(Figure 13A). VMAT2 is thus not being rerouted to the constitutive secretory pathway by
default in absence of HID-1. This observation raises the intriguing possibility that VMAT2
might be able to sort onto LDCVs lacking a dense core. To test this directly, we transfected
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WT and HID-1 KO PC12 cells with VMAT2 fused to pHluorin (Asensio et al., 2010, Onoa
et al., 2010) and monitored individual exocytotic events using live-imaging (Figure 13B).
As expected, WT PC12 cells displayed very few events under basal conditions, but showed
a massive response to depolarization. Consistent with our flow cytometry data, the number
of non-stimulated exocytotic events in HID-1 KO cells remained unchanged, again
suggesting that VMAT2 is not being rerouted to the constitutive secretory pathway.
However, we observed a dramatic reduction in the amount of events triggered by
depolarization, suggesting that VMAT2 does not sort onto “empty” LDCVs in absence of
HID-1. As a complementary approach, we developed an assay to assess monoamine
secretion taking advantage of the false fluorescent neurotransmitter (FFN206), which is a
VMAT substrate (Hu et al., 2013). After loading WT and HID-1 KO PC12 cells with
FFN206, we measured the fluorescence of secreted and cellular fractions under basal and
stimulated conditions using a plate reader. Similar to the effect observed with SgII, we
found that loss of HID-1 led to a decrease in basal storage as well as both basal and
regulated secretion of FFN206. However, normalization of the secretion data to the cellular
content showed no difference in regulated secretion per se (Figure 13C-E). Altogether,
these data indicate that the absence of HID-1 reduces the number of VMAT2-positive
LDCVs available for regulated exocytosis, but also suggest that VMAT2 does not sort onto
“empty” LDCVs.
If the number of VMAT2 positive LDCVs available for release is reduced, but
VMAT2 does not traffic to the plasma membrane constitutively, where does excess
VMAT2 accumulate? To address this, we immunostained WT and HID-1 KO PC12 cells
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transfected with VMAT2-HA, and determined the steady-state localization of the
transporter. The images revealed VMAT2 enrichment in the perinuclear area, suggesting
that the transporter might get retained in the Golgi area. Consistent with this, we observed
an increase in the amount of VMAT2 overlapping with TGN38 (Figure 13F). Finally, we
also determined the steady-state localization of an endogenous transmembrane LDCV
cargo. Immunostaining for Syt1 showed that this marker similarly accumulates in the TGN
area (Figure 13G).

Discussion
These results establish that the peripheral membrane protein HID-1 is required for
LDCV biogenesis from rat neuroendocrine PC12 cells. The absence of HID-1 leads to
defects in both storage and secretion of SgII as well as monoamines. Our phenotype is
consistent with earlier studies in worms showing a decrease in accumulation and release of
neuropeptides (Mesa et al., 2011, Yu et al., 2011). More recently, it has been reported that
conditional KO mice, in which HID-1 has been specifically inactivated from beta-cells of
the pancreas, display impaired insulin secretion. This phenotype has been attributed to a
defect in homotypic fusion of immature insulin granules (Du et al., 2016), a mechanism
that is somewhat surprising considering that this fusion process had never been previously
observed in this cell type. Although we cannot definitively rule out that this might
contribute to our phenotype, we did not observe any obvious defects in LDCV homotypic
fusion in our HID-1 KO PC12 cells by electron microscopy. It is also important to note
that immature LDCVs can still undergo exocytosis in PC12 cells (Tooze et al., 1991). Thus,
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it is unlikely that our secretion defect is caused uniquely by a maturation defect. Instead,
given its enrichment at the Golgi, we propose that HID-1 controls a step upstream of LDCV
maturation, probably at the level of budding at the TGN.
In agreement with this, we found that the absence of HID-1 leads to a striking
mislocalization of a2 concomitant with a significant alkalinization (pH > 6.9) of the TGN.
The pH value obtained for WT PC12 cells using our sialyltransferase-pHluorin reporter
fall within the range (5.6-6.6) of values reported for various cell types using other
genetically encoded reporters or pH sensitive dyes (Wu et al., 2000, Demaurex et al., 1998,
Anderson and Pathak, 1985, Maeda et al., 2008, Llopis et al., 1998, Wu et al., 2001).
Furthermore, treatment with BafA1 only had a minimal effect on TGN pH of HID-1 KO
cells, suggesting that impaired V-ATPase activity, likely caused by a2 mislocalization, is
the major factor contributing to the dysregulation of TGN pH observed in absence of HID1.
This defect in TGN acidification is likely to prevent dense core formation by
impairing granin aggregation. Indeed, previous studies have demonstrated that pH values
of 6.9 or above dramatically impair granin aggregation (Chanat and Huttner, 1991).
Consistent with this, we observed a dramatic reduction in the total number of vesicles with
a discernable dense core by electron microscopy. In addition, the few remaining LDCVs
exhibited smaller cores and displayed abnormal biochemical properties with a shift of SgII
towards lighter sucrose fractions after equilibrium sedimentation. Given the known
significance of core formation for efficient sorting of soluble cargo to the RSP, we expected
SgII to be missorted to the constitutive secretory pathway by default. Surprisingly, basal
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secretion of SgII remained unchanged in HID-1 KO cells, and instead, we found that a
fraction of SgII was rerouted to the lysosome. We propose that lack of SgII aggregation
leads to its dilution and diffusion throughout the endomembrane system (Figure 14).
Alternatively, defective LDCVs might be targeted for degradation after budding from the
TGN by crinophagy (Orci et al., 1984).
As the expression of HID-1 is restricted to specialized secretory cells (Wang et al.,
2011), it raises the question of why would HID-1 be needed in some cell types but not
others. Indeed, the existence of an acidic Golgi apparatus is not specific to secretory cells
but rather a general feature of eukaryotic cells. It is tempting to speculate that HID-1 acts
as a gatekeeper to prevent a2 from leaking into the RSP (Figure 14). In PC12 cells,
knockdown of a1, the isoform enriched on LDCVs, is not sufficient to impair LDCV
acidification, but double knockdown of both a1 and a2 leads to alkalinized LDCVs,
suggesting that a2 has the propensity to escape onto LDCVs (Saw et al., 2011). In absence
of an efficient retention mechanism, the continuous budding of LDCVs and other vesicles
might effectively deplete a2 from the TGN. It will be interesting to test this in the future
by assessing whether HID-1 is able to interact directly with a2 or whether it mediates its
effect indirectly through another partner. Another explanation could be related to the
biochemical properties of the secretory cargo that specialized secretory cells need to
accommodate. Indeed, with a predicted isoelectric point of ~4.7, both SgII and
chromogranin A are acidic proteins carrying a net negative charge at neutral pH. As these
proteins are expressed at very high level in most specialized secretory cells, they might
significantly increase the buffering capacity of the biosynthetic pathway of these cells
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Figure 14. Model of HID-1 function.
HID-1 acts as a gatekeeper preventing a2 from diffusing out of the TGN. Loss of HID-1
prevents TGN acidification, which in turn impairs LDCV soluble cargo condensation and
dense core formation. Disruption of protein aggregation leads to diffusion of soluble LDCV
cargos throughout the endomembrane system with a portion being routed to the lysosome
for degradation. Inefficient core formation effectively reduces the number of budding
LDCVs and causes LDCV-resident transmembrane proteins to accumulate at the TGN.
Alternatively, defective LDCVs could be degraded by crinophagy.

86

making it harder to build a pH gradient. These secretory cells might thus rely on some
additional mechanisms to ensure efficient Golgi acidification and HID-1 might play an
important role by influencing a2 localization.
We have previously observed that knockdown of AP-3 or VPS41 leads to defects
in SgII storage and regulated secretion together with constitutive delivery of
transmembrane LDCV cargoes to the cell surface suggesting that these cytosolic factors
recruit and concentrate membrane
proteins onto LDCVs (Asensio et al., 2010, Asensio et al., 2013). In striking contrast,
transmembrane LDCV cargoes do not traffic constitutively to the plasma membrane in
absence of HID-1, but instead, accumulate in a perinuclear compartment where they
partially overlap with TGN markers. In addition, although loss of HID-1 also results in
defects in SgII storage, regulated secretion per se, when normalized to cellular stores,
remains unchanged. Thus, the few LDCVs budding from the TGN of HID-1 KO cells must
be fully competent for regulated exocytosis, and presumably have the proper membrane
protein composition. This suggests that HID-1 does not influence the ability of the
cytosolic sorting machinery to interact with transmembrane cargoes. So, why do Syt1 and
VMAT2 display TGN enrichment? We propose that inefficient core formation not only
reduces the efficiency of soluble cargo sorting, but also influences the total number of
budding vesicles. If transmembrane cargoes can still interact with the cytosolic sorting
machinery, then reductions in the amount of budding would result in their accumulation at
the TGN with the cytosolic sorting machinery effectively preventing them from leaking
into the constitutive secretory pathway.
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Future Directions
Despite our robust characterization of HID-1 in this body of work, there still
remains unanswered questions. One of the most profound defects we observed in the
absence of HID-1 is the significantly alkalized lumen of the TGN. We assume this is due
to mislocalization of the a2 subunit of the V0 complex based on our sedimentation
gradients, leading us to propose that HID-1 acts as a gatekeeper for this subunit. Due to our
antibody being insufficient for immunofluorescence, it will be important to visualize the
a2 subunit within cells by expressing a fluorescently tagged form. This will allow us to
more accurately determine what organelles the a2 subunit is residing on in the absence of
HID-1. It will also be of great interest to test if HID-1 is truly acting as a “gatekeeper” to
retain the a2 subunit at the TGN. This could be mediated by a direct protein-protein
interaction between a2 and HID-1. Alternatively, there could be an intermediary protein
acting as a tether between HID-1 and the a2 subunit that cannot be properly recruited to
the TGN in the absence of HID-1. Another possibility is HID-12 acting as a retrograde
tether for proper a2 recycling. While the a2 subunit primarily resides at the Golgi,
subpopulations can be found on vesicle membranes (Saw et al., 2011). This leaves the
possibility that HID-1 may assist in returning the a2 subunit back to the TGN following
dissociation from the complex when mislocalized on other carrier vesicles.
The observation of small electron dense cores within LDCVs of cells lacking HID1 combined with perturbed TGN pH led us to speculate that soluble LDCV cargoes were
not efficiently aggregating and were diffusing throughout the endomembrane system
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(Figure 14). Consistent with this, inhibition of lysosomal proteases restored a small
fraction of SgII (Figure S7). This will be interesting to directly test using the RUSH
system. By tracking soluble cargoes throughout the biosynthetic pathway, combined with
fluorescent reporters for various organelles (e.g., early endosomes, recycling endosomes,
lysosomes, etc.), we will be able to directly test this hypothesis to determine the exact fates
of LDCV cargoes. Additionally, this approach will allow us to determine if crinophagy or
LDCV turnover is also occurring within HID-1 KO cells due to excess defective LDCVs.
HID-1 expression has been found to be restricted to specialized secretory cell types
(Wang et al., 2011). It will be interesting to test if HID-1 plays a similar role within other
endocrine cell types. In pancreatic β-cells, loss of HID-1 has been shown to only perturb
the pH of insulin granules rather than the TGN (Du et al., 2016), potentially suggesting a
slightly different role in this cell type. HID-1 is also specifically expressed in the brain and
in adipocytes (Weingarten et al., 2016), cell types that have significantly different roles
than chromaffin PC12 cells.
While we have characterized phenotypes arising from HID-1 ablation, the exact
molecular function of HID-1 is still to be determined. HID-1 shares close homology with
only one other protein, Dymeclin, which has been shown to be important for maintaining
Golgi structure and endochondral bone formation during early development (Denais et al.,
2011). Thus, determining if HID-1 mediates protein retention at the Golgi, membrane
composition or remodeling, or as a Golgi tether will be critical to identifying its exact role
within the RSP.
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Chapter Five: A novel membrane binding domain in conjunction with Golga5
recruits the dense core vesicle biogenesis HID-1 to the Golgi

Introduction
Initial bioinformatic analysis of HID-1 amino acid sequence predicted the presence
of several transmembrane spanning domains (Ailion & Isolation, 2003). However,
subsequent work demonstrated that HID-1 behaves as a peripheral membrane protein that
associates with the TGN from the cytosol (Wang, et al., 2011). Besides the presence of an
N-myristoyl, HID-1 has no predicted quintessential lipid binding domains, protein-protein
interacting domains, or any other known domains, and thus the mechanism by which it
associates with the TGN remains completely unknown.

Results
HID-1 N-terminus mediates membrane binding but is not strictly required for TGN
localization
We have previously generated HID-1 KO PC12 cells using a genome-editing
strategy that led to the fusion of tdTomato in frame directly after the first 22 amino acids
(N22) of HID-1 (Hummer, et al., 2017). Interestingly, we noticed that the signal of our
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fluorescent reporter was not purely cytosolic but rather perinuclear, suggesting that the
HID-1 N-terminus might be sufficient for membrane binding. As HID-1 is N-myristoylated
(Takamitsu, et al., 2015), we thus decided to focus on this part of the protein first. For this,
we transfected PC12 cells with N22 fused to GFP (N22-GFP) and found that this reporter
indeed displayed apparent membrane binding, which was resistant to cytosolic extraction
using saponin pre-fixation (Fig. S8A). We obtained similar results by transfecting this
construct in INS-1 cells (Fig. 15A). As INS-1 cells are bigger, flatter, and more amenable
to imaging than PC12 cells, we have relied on INS-1 cells for imaging experiments and
PC12 cells for functional experiments for the remainder of this study. We further observed
that membrane association of N22 depends on N-myristoylation as a G2A N22 mutant
(N22G2A) redistributed to the cytosol and washed away completely during saponin
pretreatment (Fig. 15A, Fig. S9A).
Typically, N-myristoylation per se is not sufficient for membrane targeting and
only promotes weak interaction with the membrane. This type of lipidation is thus often
found in combination with other motifs or modifications (Farazi, et al., 2001). In some
cases, the presence of additional lipid modifications, such as palmitoylation, increases
membrane binding affinity and specificity, but analysis of the HID-1 N22 sequence failed
to identify additional predicted lipidation sites. Alternatively, the myristoyl group can be
found in association with polybasic amino acid patches (Farazi, et al., 2001), and HID-1
has three conserved basic residues in its first 22 amino acids (Fig. S8B). In other cases, the
myristate moiety increases membrane affinity by rendering an N-terminal alpha-helix more
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Figure 15. HID-1 N-terminus mediates membrane affinity.
(A) INS-1 cells were co-transfected with sialyltransferase-RFP657 and indicated GFP
constructs. Cells treated or not with saponin were fixed and imaged. (B) INS-1 cells were
transfected with WT, G2A or ∆22 HID-1-HA and treated or not with saponin before
fixation and immunostaining for HA and TGN38. The bar graph indicates quantification
of HA signal at the TGN. (C-E) INS-1 HID-1 KO cells stably expressing WT or G2A HID1-GFP were transiently transfected with sialyltransferase-RFP657 and analyzed by
fluorescence loss in photobleaching. Quantification of the change in fluorescence at the
TGN is shown in (D) and determination of the decay slope in (E). *, p<0.001; WT n=22
cells, G2A n=21 cells, from 3 independent sialyltransferase-RFP657 transfections. Scale
bar indicates 10μm.
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amphipathic, as it has been shown for both Arf and Arl proteins (Farazi, et al., 2001;
Lundmark, et al., 2008). Of note, the first 17 amino acids of HID-1 are predicted to fold as
an alpha-helix, and this fragment (N17) is indeed sufficient for membrane binding (Fig.
15A, Fig. S8A). To distinguish between the two possibilities, we reasoned that replacement
of positively charged amino acids with alanine (K7A, R11A, K12A; N17KRK) should
affect both motifs, whereas substitution of hydrophobic residues for polar residues (F10Q,
V14Q, L17Q; N17FVL) should only affect a putative amphipathic helix. Strikingly, the
N17KRK mutant displayed a completely cytosolic distribution, whereas the N17FVL
construct was resistant to saponin extraction (Fig. 15A, Fig. S8A). Altogether, these results
suggest that a myristoyl group and a polybasic patch within the first 17 amino acids of the
N-terminus of HID-1 mediate membrane binding.
Although the N-terminus of HID-1 is capable of membrane binding, our reporter
did not show particular enrichment at the TGN as evidenced by the lack of co-localization
with a co-transfected TGN marker (sialyltransferase-TagRFP657) (Fig. 15A, Fig. S8A).
To directly test whether the N-terminus is required for HID-1 localization, we generated
HID-1 KO INS-1 cells using CRISPR/Cas9. As there are currently no commercially
available antibodies for HID-1 western blotting, we validated our HID-1 KO by indel
sequencing and immunofluorescence (Fig. S9A-E). We then used lentivirus to stably
reintroduce HA tagged wildtype (WT), myristoylation deficient (G2A), or N-terminal
deletion (Δ22) versions of HID-1 (Fig. S10). Although the G2A and Δ22 mutants displayed
a greater amount of cytosolic signal at steady-state when compared to WT HID-1, prefixation saponin extraction revealed the presence of a pool co-localizing with a TGN
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marker (Fig. 15B). These observations suggest that the N-terminus of HID-1 increases its
affinity for membrane but is not strictly required for TGN localization. Consistent with
this, fluorescence loss in photobleaching (FLIP) experiments comparing WT and G2A
HID-1-GFP confirmed that the absence of the myristoyl moiety partially decreases HID-1
TGN immobile pool from 66.3±4.6% for WT to 30.3±3.1% for G2A HID-1-GFP (Fig.
15C-E).

HID-1 myristoylation is not required for function
We next tested whether the residual TGN pool observed for G2A HID-1 is
functional. To determine this, we first generated PC12 HID-1 KO using CRISPR/Cas9
(Fig. S9A-E) and we co-immunostained HID-1 KO PC12 cells expressing WT or G2A
HID-1-HA for HA and SgII (Fig. 16A). We found that G2A could indeed restore cellular
SgII levels in a dose-dependent manner. In contrast, WT HID-1 rescued SgII cellular
accumulation independently of its level of expression (Fig. 16B,C). To further evaluate
whether this rescue led to functional LDCVs, we overexpressed G2A HID-1-HA using
lentivirus in HID-1 KO cells and found that it was indeed sufficient to fully rescue the
defect in SgII storage and secretion (Fig. 16D-F). These data indicate that, although
myristoylation increases membrane affinity, it is not an absolute requirement for HID-1
function. It further suggests that an additional domain within HID-1 is responsible for
proper TGN targeting.

HID-1 myristoylation is not required for membrane binding in vitro
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Figure 16. HID-1 N-terminus does not contribute to HID-1 function.
(A) HID-1 KO PC12 cells stably expressing HID-1 HA WT or G2A were immunostained
for secretogranin II (SgII) and HA. (B-C) Immunoreactivity was quantified and binned. *,
p < 0.0001 relative to WT (n=183 cells for WT and 190 cells for G2A from two independent
coverslips). (D-F) HID-1 KO PC12 cells transduced with indicated HID-1-HA lentivirus
were washed and incubated for 30 minutes in Tyrode’s solution containing 2.5 mM K+
(basal) or 90 mM K+ (stimulated). Cellular and secreted SgII were measured by
quantitative fluorescent immunoblotting (D), with the secreted SgII normalized to tubulin
and expressed as percent of basal secretion in the KO (E), and the cellular SgII normalized
to tubulin (F). *, p < 0.01 relative to WT (n=4). The bar graphs indicate mean ± s.e.m.
Scale bar indicate 20μm.

95

We then assessed whether full-length HID-1 showed any membrane binding. For
this, we purified rat WT HID-1 from insect cells using a baculovirus expression system in
order to get full-length myristoylated recombinant protein. Multi-angle static light
scattering after size exclusion revealed that recombinant HID-1 behaved as a monodisperse
monomer (Fig. S11A), and circular dichroism (CD) analysis revealed that the protein is
mostly alpha-helical (Fig. 17A). Analysis of flotation assays showed that full-length HID1 can indeed bind to liposomes (80% DOPC, 20% POPC) (Fig. 17B). HID-1 bound
similarly to liposomes extruded at 1µm or 0.1µm, indicating no membrane curvature
preference (Fig. 17C). We next determined whether full-length HID-1 displays any
specificity towards particular phospholipids, which could help explain the precise
localization at the TGN. Although, we observed some binding of WT HID-1 to various
phosphatidylinositols and phophatidylserine using PIP strips, it remained extremely weak
in comparison to the positive control (GRIP domain) (Fig. S11C-E). In addition,
recombinant G2A HID-1, which also behaves as a monodisperse monomer after
purification and is also mostly alpha-helical by CD (Fig. 17D, Fig. S11B) showed no
binding at all, suggesting that the presence of the myristoyl moiety is likely mediating weak
non-specific interactions with these particular phospholipids. To further substantiate this
finding, we performed additional liposome flotation assays with recombinant WT HID-1
and confirmed the lack of preferential binding to TGN-enriched PI(4)P (Fig. 17C).
Interestingly, recombinant G2A HID-1 bound to liposomes to the same extent as WT HID1, indicating the existence of another membrane binding domain within HID-1 (Fig.
17E,F).
96

B

WT

10

0

C

-5

-10
200

250

300

Wav elength (nm)

350

80
60
40
20
0

G2A

-1
MRE [deg cm² dmol
]

PC 0.1 µm

PI(4)P 0.1 µm

PC 1.0μm

PC 0.1μm

G2A

0

F

-5

-10
-15
150

PC 1.0µm

E

5

200

250

300

Wav elength (nm)

350

liposome bound protein (%)

D

PI(4)P 0.1μm

WT

5

-15
150

PC 0.1μm

PC 1.0μm

liposome bound protein (%)

-1
MRE [deg cm² dmol
]

A

80
60
40
20
0

PC 1.0µm

PC 0.1 µm

Figure 17. HID-1 can directly bind lipids.
(A) Circular dichroism (CD) spectra of recombinant of rat WT HID-1. (B) Liposome
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Identification of the minimal domain responsible for membrane binding and TGN
targeting
We next set out to identify the minimal domains responsible for membrane binding
and TGN localization. As HID-1 does not have any predicted membrane binding motifs or
protein interaction domains, we designed a series of truncations in order to
identify the region responsible. Interestingly, C-terminal truncations (1-686 and 1-583) or
N-terminal truncation (321-788) stably expressed in HID-1 KO INS-1 cells still localized
to the TGN to some extent (Fig. 18A), suggesting that the TGN binding domain is
comprised within residues 321 and 583. Consistent with this, stable expression of HID-1HA321-583 colocalized with TGN38 after saponin extraction. In addition, HID-1 C-terminus,
which displays a very high degree of conservation across species (Fig. S12), also mediates
membrane binding. Indeed, we observed that constructs including the C-terminus (amino
acids 583-788 and 686-788) displayed non-specific membrane binding after saponin
extraction pre-fixation. Altogether, the data indicate that HID-1 relies on three separate
domains for efficient membrane binding and TGN localization.

HID-1-HA321-583 does not bind to lipids in vitro, but interacts with the Golgi tether
Golga5
We next tested whether the TGN binding domain could bind lipids directly. For
this, we expressed a GST fusion of this domain (amino acids 321-583) in bacteria. As this
fragment proved to be completely insoluble, we redesigned our construct to remove the
predicted unstructured regions at the two termini and we successfully purified an MBP
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fusion of this shorter fragment (amino acids 365-551) (Fig. S13A). Performing liposome
flotation assays to assess membrane binding (Fig. 19A), we found that this recombinant
fragment cannot bind to liposomes (80% DOPC, 20% POPC). Our results indicate that
HID-1365-551 is required for TGN targeting, but is not involved in membrane binding,
suggesting that protein-protein interactions likely contribute to HID-1 targeting to the
TGN.
To identify potential interactors, we relied on proximity labeling using BioID2
(Kim, et al., 2016). We fused BioID2 to HID-1 using a short (HID-1-BioID2-HA) or a long
(HID-1-13x-BioID2-HA) linker, which we stably expressed in HID-1 KO INS-1 cells. As
a control, we used a soluble, cytosolic form of BioID2 (Kim, et al., 2016). We verified that
our constructs expressed as full-length proteins (Fig. 19B) and that they localized properly
by immunofluorescence (Fig. S13B). Overnight treatment with biotin led to substantial
labelling as revealed by western blot (Fig. 19B) or by imaging using fluorescently labelled
streptavidin (Fig. S13C). Analysis of streptavidin pulldown elutions by mass spectrometry
revealed a small subset of proteins enriched in HID-1-BioID2 expressing cells (Fig. S13D).
Of the interactors obtained with the short and long linker constructs, Golga5 emerged as
the most promising hit. Golga5 belongs to the golgin family, and localizes throughout the
Golgi in non-endocrine cells (Diao, et al., 2003; Satoh, et al., 2003). In INS-1 and PC12
cells, Golga5 partially overlaps with TGN38 (Fig. S13E). We confirmed our mass
spectrometry results by analyzing BioID2 elutions by western blot using an anti-Golga5
antibody (Fig. 19C). As HID-1321-583 is sufficient for TGN localization but does not bind
to lipids, we reasoned that this motif might bind to Golga5 instead. Consistent with this,
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Figure 19. Identification of HID-1 protein interactors.
(A) Liposome flotation assays using recombinant HID-1365-551 fragment were
immunoblotted to detect liposome bound protein. (B) HID-1 KO INS-1 cells stably
expressing the indicated BioID2 constructs were incubated with biotin overnight before
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101

MBP-HID-1365-551 efficiently pulled down Golga5 from PC12 cell lysate (Fig. 19D).
Interestingly, we further found that recombinant full-length WT HID-1 did not pull down
Golga5 from PC12 cell lysates, but full-length G2A did (Fig. 19E). Altogether, these
results indicate that HID-1 interacts with Golga5 through amino acids 365-551 and that
this domain might be inaccessible in the myristoylated form of full-length WT HID-1. This
suggests that the myristoyl group could act as a conformational switch, exposing HID-1365551

only upon membrane binding only. Consistent with this, negative stain electron-

microscopy (EM) of purified, recombinant WT and G2A HID-1 indicated the presence of
two different conformations. Under these in vitro conditions, WT HID-1 exists mostly as
a closed, compact structure, whereas G2A HID-1 exists as an open, elongated particle (Fig.
S14).

Golga5 contributes to HID-1 localization at the TGN
We next tested whether Golga5 is required for HID-1 cellular localization. For this,
we generated pools of Golga5 KO INS-1 cells, which contain a mixed population of WT
and KO cells, using CRISPR/Cas9 and scored cells for the presence of HID-1 at the TGN.
Although the effect was not observed in every cell, HID-1 TGN localization was lost in a
significantly higher proportion of Golga5 KO cells compared to WT cells (Fig. 20A,B).
We obtained similar results using siRNA against Golga5 in PC12 cells (Fig. 20C,D).
Although this indicates that Golga5 contributes to HID-1 TGN targeting, it also
suggests that other factors might be involved. We reasoned that overexpression of the
cytosolic domain of Golga5, by outcompeting HID-1 binding to other interactors, should
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cause its redistribution away from the TGN and should lead to a more robust phenotype.
In agreement with this, HID-1 completely redistributed away from the TGN in INS-1 cells
overexpressing GFP-Golga5cyto (Fig. 20E,F). Of note, we also observed that the total
cellular amount of HID-1 increased substantially in these cells. Western blot analysis
confirmed this observation (Fig. S15), suggesting that the presence of Golga5cyto or
redistribution away from the TGN might contribute to stabilize HID-1. We conclude that
Golga5 interacts with HID-1 and influences its ability to target to the TGN.

The highly conserved C-terminus of HID-1 contains a novel membrane binding
domain and serves as the functional domain
The observations that recombinant G2A HID-1 binds membrane efficiently in vitro
whereas HID-1365-551 does not and that HID-1686

-788

is sufficient to associate with

membranes in HID-1 KO cells strongly suggest that this latter region represents a lipid
binding domain. To test this directly, we expressed and purified recombinant MBP-HID1682-788 from bacteria (Fig. 21A) and performed liposome flotation assays. We found that
HID-1682 -788 binds to liposomes (80% DOPC, 20% POPC) (Fig. 21B,C). As HID-1 Cterminus displays no homology to known lipid binding domains, these data indicate that it
acts as a previously uncharacterized membrane binding domain.
Interestingly, a human patient with severe endocrine and neurological deficits
carries a homozygote mutation within HID-1 (Monies, et al., 2017). This base-pair
duplication leads to a frameshift at the end of HID-1 C-terminus (Fig. S12). The result of
this mutation is predicted to swap the last 15 amino acids (IWYDTDVKLFEIQRV) for 9
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amino acids (LVRHRREAV). Interestingly, stable expression of this mutant in HID-1 KO
PC12 cells led to its partial dissociation from the TGN (Fig. 22A). Even more dramatically,
this mutant completely failed to rescue the secretion phenotype observed in HID-1 KO
cells (Fig. 22B-D). These data indicate that a defect in LDCV formation is the underlying
cause of the symptoms associated with this patient. Altogether, these data indicate that the
highly conserved C-terminus of HID-1, in addition to mediating direct membrane binding,
also represents its functional domain. Indeed, constructs missing the C-terminus (1-583)
and (1-686) stably expressed in HID-1 KO PC12 cells fail to rescue the defect in SgII
regulated secretion (Fig. 22E-G, Fig. S16).
Finally, to further assess whether the C-terminal domain is sufficient to mediate
function, we fused HID-1686-788 to the C-terminus of GFP-TGN38 in order to constitutively
localize it to the TGN. HID-1 KO PC12 cells transiently expressing this fusion protein
displayed restored SgII cellular content and regulated secretion (Fig. 23A-D). This
construct also rescued the perinuclear accumulation of Syt1 associated with the absence of
HID-1 (Hummer, et al., 2017), indicating that this domain is sufficient to fully rescue the
HID-1 KO phenotype (Fig. 23E, F).

Discussion
Transient association of cytosolic proteins to membranes is characteristic of many
factors involved in membrane trafficking. In this study, we explored the mechanisms by
which HID-1 specifically targets to the Golgi from the cytosol and we show that for it do
so, it relies on three separate domains (Fig. 24A). The first one lies within the N-terminus
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Figure 22. HID-1 C-terminus is essential for function.
(A) HID-1 KO PC12 cells stably expressing WT HID-1 or the human mutant was
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of HID-1 and includes an N-terminal myristoyl together with a conserved polybasic patch.
However, our experiments using N22-GFP confirmed that this motif alone is not sufficient
for proper Golgi targeting. Second, we identified a novel membrane binding region within
the highly conserved C-terminus that can directly bind lipids, albeit in a non-specific
manner. Finally, HID-1 relies on a region found within amino acids 321-583 that mediates
an interaction with Golga5, a member of the golgin family. The absence of the N-terminus
or the C-terminus leads to HID-1 redistribution to the cytosol, with a small pool remaining
at the Golgi. We thus propose that the N-terminus and a region within the conserved Cterminus mediate non-specific membrane binding and that interaction with Golga5
provides targeting specificity for the Golgi. It is important to note that we did not observe
a HID-1 redistribution phenotype in all KO or KD Golga5 cells. However, overexpression
of GFP-Golga5cyto led to a robust phenotype. This indicates that HID-1 may well bind to
other factors in addition to Golga5.
Proteins of the golgin family are thought to act as either matrix proteins to ensure
proper Golgi ribbon formation or as tether to recruit vesicles and other proteins to the Golgi
(Gillingham & Munro, 2016; Lowe, 2019). In the case of Golga5, its exact role remains
less robustly characterized. It can interact with COPI vesicles and the conserved oligomeric
Golgi (COG) complex, suggesting a role as a tethering protein in intra-Golgi transport
(Sohda, et al., 2010). Additionally, loss of Golga5 results in Golgi ribbon fragmentation
(Diao, et al., 2003; Sohda, et al., 2010). However, in our hands, we did not observe any
obvious changes in Golgi structure in absence of Golga5 in PC12 cells or INS-1 cells,
suggesting that there may well be variability between cell types. In terms of localization,
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Golga5 localizes throughout the Golgi and seems to be enriched at the rim of stacks (Diao,
et al., 2003; Satoh, et al., 2003). In INS-1 and PC12 cells, Golga5 overlaps significantly
with TGN38 and sialyltransferase, suggesting that there is a pool of Golga5 at the trans
face of the Golgi. Functionally, Golga5 interacts with Rab1 and, interestingly, knockdown
of Golga5 in INS-1E cells led to a reduction in insulin content (Liu, et al., 2016). This
phenotype is similar to the one observed in INS-1E HID-1 KO cells and in islets of mice
with a deletion of HID-1 specifically in β-cells (Du, et al., 2016). Altogether, this suggests
that Golga5 contributes to recruit HID-1 to the Golgi and this recruitment is essential for
HID-1 function within the regulated secretory pathway.
HID-1365-551 is able to pulldown Golga5, but, surprisingly, full-length HID-1 is
unable to. Interestingly, the G2A HID-1 mutant can interact with Golga5. It is thus
tempting to speculate that the myristoyl moiety acts as a conformational switch. The lipid
anchor buries itself within the protein in absence of membranes, corresponding to a closed
conformation that prevents interaction with Golga5 or other targeting factors. In presence
of membranes, the lipid anchor becomes exposed, which leads to a change in conformation
that subsequently enables interaction with Golga5. (Fig. 24B).
The observation that the G2A mutant could still bind to membrane efficiently in
vitro suggested the presence of another membrane binding region. We mapped this domain
to the C-terminus. Despite very high-conservation, this region displays no similarity to any
known lipid-binding domains. De novo structure prediction indicates the presence of four
potential alpha-helices and 2 β-sheets (Fig. 24C). One of these helices has a large predicted
hydrophobic face that could potentially fold as an amphipathic helix (Fig. 24D).
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Interestingly, the unusual presence of a proline in the middle of this helix could form a kink
in this secondary structure, as it has been reported previously in the context of other
proteins (Yun, et al., 1991). It will be interesting to further characterize the exact
mechanisms by which this novel domain interacts with lipids in the future. In addition to
membrane binding, this region, when directly tethered to the TGN, is also sufficient to
completely rescue the phenotype of HID-1 KO PC12 cells, indicating that it also represents
the HID-1 functional domain. It will be important to further delineate the minimum
membrane binding domain and functional domain within the C-terminus. Indeed, a
complete overlap might suggest that HID-1 function could be related to lipid binding or
shuttling.
Finally, the experiments with the mutation (Monies, et al., 2017), associated with
endocrine and neurological deficits in humans, provides a basis for understanding the
phenotype of this patient. It further demonstrates that HID-1 plays a key role in the
regulated secretory pathway and unraveling its mechanisms of action might help us
understand better diseases of the endocrine system and of the brain.

Future Directions
While this study has made an adamant effort to characterize HID-1 and begin the
process of domain mapping, many questions still remain. One of the most confounding
findings from this work is the apparent intermediate phenotype regarding the HID-1 –
Golga5 interaction. Despite the robust effect on HID-1 localization following the loss of
Golga5, the phenotype is not present in every cell, suggesting that other protein
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interactions that mediate the TGN association of HID-1 are present. There exists many
tethering proteins at the Golgi and the golgin family is expansive (Witkos & Lowe,
2015), thus it may be a combined effort of multiple golgin tethers that mediate HID-1
TGN association. Golga5 has been primarily observed at the rim of Golgi stacks seeming
to lack any preference for specific Golgi cisternae (Diao, et al., 2003; Satoh, et al., 2003),
which complicates the interaction with HID-1 which primarily resides on the more transaspects of the Golgi. There are golgin proteins that do primarily localize to the TGN,
namely Golga4 (Witkos & Lowe, 2015). Further investigation into other potential
binding partners will be important to determine how HID-1 specifically localize to the
TGN and may require the knockdown or KO of multiple proteins simultaneously to
completely abolish HID-1 binding.
Following determination of what proteins HID-1 specifically interacts with,
further mapping of the interface of these interactions will be of great interest. Golga5, for
example, has a large coiled-coil domain within its cytoplasmic domain. Additionally,
HID-1 is predicted to have multiple coiled regions throughout the majority of the protein.
Thus, it would be interesting to determine which, if any, of these coiled regions interact
with Golga5. Furthermore, these various coiled regions of HID-1 could interact
specifically with other coiled-coil domain containing proteins for greater modality of
protein binding.
One of the most interesting findings from this body of work is the existence of a
potentially novel membrane binding region, requiring further investigation into its
characteristics. While we have determined that HID-1686 -788 doesn’t appear to have any
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preference for charged lipids, further investigation into different lipid species, such as
sphingolipids, will help further characterize this novel domain. Confoundingly, this
region also doesn’t appear to have any membrane curvature preference, demonstrating
that region appears to be either a ubiquitous or promiscuous membrane binding domain.
Due to the apparent ambivalent nature of this putative membrane binding domain, it
necessitates advanced techniques to further our understanding of this region. The use of
X-ray crystallography of HID-1 would allow us to not only determine the 3D structure of
the protein, but also map the points of contact between the protein-lipid bilayer. Further,
analysis of the non-myristoylated form of HID-1 using this technique would allow further
insight into the potential existence of the proposed myristoyl switch and if the
conformation of HID-1 is necessary for membrane binding. Unfortunately, membrane
associated proteins do not readily crystallize (Hsia, et al., 2015), potentially resulting in
the complete inability to generate lipid-protein complexes of HID-1. Another option is
crystallization of the minimal membrane binding domain to determine its exact 3D
structure. HID-1 shares little homology with other known peripheral membrane proteins
and contains no previously described lipid binding domains, thus solving of the 3D
structure of this novel region and subsequent comparison with known lipid binding
domains may gain further insight into the lipid preferences of this region.
An alternative approach to X-ray crystallography for investigating protein-lipid
binding is isothermal titration calorimetry (ITC). This technique measures binding
interactions by detecting the enthalpy, or the amount of heat absorbed or released, during
a binding reaction (Doyle, 1997). The power of this technique is the accuracy of
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measurement and the use of native molecules. The use of native molecules allows for
precise determination of binding stoichiometry. This is important for analysis of the
apparent ubiquitous nature of the HID-1 novel membrane binding domain. Since ITC can
detect nanomolar affinities (Doyle, 1997), the binding profile can be measured among a
vast array of lipid species, allowing for the determination of what lipids HID-1
specifically binds to. The identification of a new novel membrane domain is not only of
great importance to understanding HID-1 but also to all of membrane binding protein
biology.
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Appendix A: Supplemental figures

Figure S1
(A) Diagrams depicting the insertion sites of GFP-SBP for the RUSH constructs used
in this study. (B) PC12 cells transfected with NPY-emdGFP-SBP as in Fig. 1,
incubated with biotin for the indicated times, fixed and imaged using a widefield
epifluorescence microscope. (C) PC12 cells transfected with NPY-emdGFP-SBP and
incubated with biotin for 1h (B) or 24h (C) and co-stained for SgII. Insets are shown in
C’. (D) Western blot using lysates from INS-1 or PC12 cells transfected with phogrin138

emdGFP-SBP or NPY-emdGFP-SBP as indicated. Asterisks indicate non-specific
bands. Scale bar indicates 10 μm and 1 μm for insets.
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Figure S2
(A) INS-1 cells were transfected with phogrin-emdGFP-SBP together with the TGN
marker sialyltransferase-TagRFP657 and ER-hook, incubated with biotin for the
indicated times, fixed and imaged using a widefield epifluorescence microscope. (B,C)
INS-1 cells were co-transfected with indicated RUSH cargoes together with an ER-hook
and imaged using an inverted widefield microscope. Cells not treated with biotin were
imaged as in Fig. 2 to measure photobleaching. n= 3 cells for NPY-emdGFP-SBP and n
140

=2 for phogrin-emdGFP-SBP. Data shown indicate mean ± SEM. (D) INS-1 cells were
transfected with phogrin-emdGFP-SBP and co-stained for insulin at the indicated times.
The extent of colocalization with insulin was determined by Manders Correlation
Coefficient (MCC) as in Fig. 3. ****p<0.0001 by one-way ANOVA followed by posthoc
Tukey t-test (3hr Biotin: n = 13 cells, 6h biotin biotin: n = 12 cells, 8h biotin: n = 8 cells).
(E) INS-1 cells were transfected as in D, incubated with biotin for 30min, and rinsed
extensively. Cells were fixed and co-stained for insulin at 1h or 8h after the washout. The
extent of colocalization was determined as in D. ***p<0.0001 (1h biotin: n = 10 cells, 8h
biotin: n = 10 cells). (F) INS-1 cells transfected with VMAT2-emdGFP-SBP were
incubated with biotin in presence or absence of 80μM dynasore. Fluorescence within the
TGN region was monitored as described in Fig. 3. Average curves of TGN fluorescence
are shown. (n=12 and 4 cells from 2 independent transfections for VMAT2-emdGFPSBP vehicle and dynasore, respectively). Data shown indicate mean ± SEM.
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Figure S3
(A) Illustration of the strategy used to generate HID-1 KO PC12 cells, relying on
homologous recombination repair after cleavage by Cas9 to knock-in a fluorescent protein
(tdTomato), while effectively knocking-out HID-1. The repair template was designed in
such a way that the fluorescent reporter should not be expressed without proper, in-frame
recombination. (B) Schematic illustrating the sequence of the homology arms flanking
tdTomato in the repair construct. (C) Genotyping PCR was performed from genomic DNA
isolated from WT and HID-1 KO cells using the indicated primers. The location of primers
with regard to the homology arms is shown in panel A. (D) The subpopulation of PCR
products corresponding to alleles without integrated tdTomato were ligated into
pBlueScript II. Plasmids were isolated from twenty-four random colonies and analyzed for
the presence of indels by sequencing. (E) Predicted protein sequences associated for the
five types of identified indels.
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Figure S4
HID-1 KO PC12 cells generated with an independent gRNA (KO#2) were plated and
subjected to a secretion assay as described in Figure 6. Cellular and secreted
secretogranin II (SgII) were measured by quantitative fluorescent immunoblotting with
the secreted SgII normalized to actin (B) or total SgII (C) and expressed as percent of
basal secretion in the control. The cellular SgII content was normalized to actin (A).
Multiple comparison statistical analysis was performed by one-way ANOVA followed by
posthoc Tukey test. ***, p < 0.001 relative to stimulated secretion from WT (n=4).
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Figure S5
Quantitative RT-PCR analysis of WT and HID-1 KO PC12 cells transcripts shows no
change in SgII expression. n=3.
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Figure S6
WT and HID-1 KO PC12 cells were transfected with ANF-GFP and subjected to a
secretion assay as described in Figure 6. Cellular and secreted ANF-GFP were measured
with a plate reader and expressed as percent of basal control values (A,B). Alternatively,
secretion was normalized to total ANF-GFP (C). Multiple comparison statistical analysis
was performed by one-way ANOVA followed by posthoc Tukey test. *, p < 0.05 relative
to WT; **, p < 0.01 relative to stimulated secretion from WT, ***, p < 0.001 relative to
stimulated secretion from WT (n=7).
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Figure S7
WT and HID-1 KO PC12 cells were incubated where indicated with protease inhibitors for
24 hours. Cellular SgII was quantified by fluorescent western analysis and the values
normalized to tubulin immunoreactivity. *, p < 0.05 relative to KO; (n=3). The data shown
indicate mean ± s.e.m.
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Figure S8
(A) PC12 cells were transfected with the indicated GFP constructs. Cells were treated or
not with saponin were fixed and immunostained for TGN38. (B) Protein sequence
alignment of HID-1 N-terminus.
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Figure S9
(A) Genomic DNA sequence of rat HID-1. The predicted Cas9 cleavage site is indicated.
(B) Indels detected in INS-1 HID-1 KO cells. (C) Indels detected in PC12 HID-1 KO cells.
(D-E) HID-1 KO PC12 and INS-1 immunostained for endogenous HID-1. Scale bars
indicate 10μm.
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Figure S10
Diagrams representing WT, G2A, and Δ22 HID-1 constructs.
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Figure S11
Recombinant WT (A) or G2A (B) HID-1 was expressed using a baculovirus system in
insect cells, purified using StrepTactin-XT beads and analyzed by Coomassie after SDSPAGE. The recombinant proteins were further purified using a size-exclusion column and
analyzed by multi-angle light scattering (MALS). PIP strips incubated with recombinant
HID-1 (C), G2A (D), or positive control GRIP domain (E) and immunoblotted for HA (C,
D) or GST (E).
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Figure S12
Protein sequence alignment of HID-1 C-terminus (103 amino acids) for the indicated
species and for the human mutation.
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Figure S13
(A) Recombinant MBP-HID-1365-551 fragment was expressed in bacteria, purified using
amylose resin and analyzed by Coomassie after SDS-PAGE. (B) INS-1 HID-1 KO
cells were transfected with BioID2-HA or HID-1-BioID2-HA, fixed and
immunostained for TGN38 and HA. (C) INS-1 cells transfected with the indicated
BioID2 constructs were treated overnight with biotin (+) or not (-) fixed, stained
using strepatividin 647 and immunostained for HA. (D) Comparison of
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biotinylated proteins purified from INS-1 cells stably expressing soluble BioID2
and HID-1-13X-BioID2. (E) INS-1 and PC12 cells were fixed and immunostained
for TGN38 and Golga5. Scale bars indicate 10μm.
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Figure S14
Negative stain electron micrographs of WT and G2A HID-1. Arrows indicate “closed”
conformation particles; arrow heads indicate “open” conformation particles. Scale bar
indicates 10nm.
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Figure S15
HID-1 KO INS-1 and PC12 cells were transfected with HID-1-HA and GFP-cytoGolga5
or GFP, lysed, and immunoblotted for HA, GFP, or actin.
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Figure S16
HA immunoblot showing expression level of indicated HID-1 constructs in stably
transduced HID-1 KO PC12 cells. Tubulin is shown as a loading control.
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Appendix B: Tables
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Table S1
Table of all primers used in the reported studies.

